"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties"
"CHEMBL1916359";"";"0";"419.67";"1";"6.30";"20";"[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1919736";"Inhibition of human TrkB";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914450";"1";"Scientific Literature";"J. Med. Chem.";"2011";"None";""
"CHEMBL3673456";"";"0";"461.52";"0";"3.31";"BDBM164905";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CCOCC5)cnc43)cc2OC)cn1";"IC50";"'='";"31.0";"nM";"7.51";"";"308464";"UO_0000065";"16.27";"0.30";"4.20";"8.96";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673485";"";"0";"499.58";"0";"4.07";"BDBM164936";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5c(C)nn(C)c5C)cnc43)cc2OC)cn1";"IC50";"'='";"13.0";"nM";"7.89";"";"308495";"UO_0000065";"15.79";"0.29";"3.82";"6.85";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2178804";"";"0";"402.25";"0";"3.27";"7j";"Cn1cc(NC(=O)c2cnn3ccc(N)nc23)c(-c2cc(Cl)ccc2Cl)n1";"IC50";"'='";"5380.0";"nM";"5.27";"";"";"UO_0000065";"13.10";"0.27";"2.00";"5.11";"0";"CHEMBL2186154";"Inhibition of TRKB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176876";"1";"Scientific Literature";"J. Med. Chem.";"2012";"None";""
"CHEMBL388978";"STAUROSPORINE";"0";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1919773";"Inhibition of TRKB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914457";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2011";"None";""
"CHEMBL3673458";"";"0";"500.60";"1";"3.76";"BDBM164907";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CCN6CCC5CC6)cnc43)cc2OC)cn1";"IC50";"'='";"349.0";"nM";"6.46";"";"308466";"UO_0000065";"12.90";"0.24";"2.70";"8.30";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673461";"";"0";"489.53";"0";"3.52";"BDBM164910";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CCC[C@H]5C(=O)O)cnc43)cc2OC)cn1";"IC50";"'='";"13.0";"nM";"7.89";"";"308469";"UO_0000065";"16.11";"0.30";"4.37";"7.05";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673463";"";"0";"509.61";"1";"4.56";"BDBM164912";"COc1cc(Cn2cnc3cc(-c4cnn(C5CCNCC5)c4)cnc32)ccc1OCc1ccc(C)nc1";"IC50";"'='";"0.6";"nM";"9.22";"";"308471";"UO_0000065";"18.10";"0.33";"4.66";"10.03";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673469";"";"0";"491.57";"0";"3.97";"BDBM164919";"COc1ccc(COc2cc(F)c(Cn3cnc4cc(N5CCN(C)CC5)ccc43)cc2OC)cn1";"IC50";"'='";"305.0";"nM";"6.52";"";"308478";"UO_0000065";"13.25";"0.25";"2.55";"10.04";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673481";"";"0";"467.53";"0";"4.72";"BDBM164932";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5ccccc5)cnc43)cc2OC)cn1";"IC50";"'='";"4.0";"nM";"8.40";"";"308491";"UO_0000065";"17.96";"0.33";"3.68";"8.63";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678297";"";"0";"522.53";"2";"5.63";"BDBM164956";"COc1cc([C@H](C)n2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"308514";"UO_0000065";"17.65";"0.33";"3.59";"9.91";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678301";"";"0";"511.50";"1";"4.36";"BDBM164964";"COc1cc(C(C)n2c(N)nc3cc(C#CCCO)cnc32)ccc1OCc1ccc(C(F)(F)F)nc1";"IC50";"'='";"1.0";"nM";"9.00";"";"308518";"UO_0000065";"17.60";"0.33";"4.64";"8.31";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1983268";"ENTRECTINIB";"4";"560.65";"2";"5.03";"2; entrectinib";"CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"15.20";"0.28";"3.49";"9.97";"0";"CHEMBL3807408";"Inhibition of recombinant human TRKB incubated for 90 mins by selectscreen kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3804811";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL3673454";"";"0";"474.57";"0";"3.22";"BDBM164903";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CCN(C)CC5)cnc43)cc2OC)cn1";"IC50";"'='";"66.0";"nM";"7.18";"";"308462";"UO_0000065";"15.13";"0.28";"3.96";"9.23";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2037209";"";"0";"568.56";"2";"7.02";"5";"Cc1cn(-c2cc(C(=O)Nc3cccc(Nc4ccc5c(c4)NC(=O)/C5=C\c4ccc[nH]4)c3)cc(C(F)(F)F)c2)cn1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"12.78";"0.24";"0.25";"7.00";"0";"CHEMBL2038861";"Inhibition of TRKB by HTRF assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034853";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2012";"None";""
"CHEMBL1097700";"";"0";"375.42";"0";"1.88";"91; 144";"CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"20.20";"0.38";"5.71";"6.53";"0";"CHEMBL3880858";"Inhibition of human TrkB after 40 mins in presence of [gamma33P-ATP] by scintillation counting";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3880411";"38";"Patent Bioactivity Data";"";"2009";"None";""
"CHEMBL1983268";"ENTRECTINIB";"4";"560.65";"2";"5.03";"2; entrectinib";"CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"15.20";"0.28";"3.49";"9.97";"0";"CHEMBL3807304";"Inhibition of human TEL (336 residues) fused-TRKB (455 to 822 residues) (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3804811";"1";"Scientific Literature";"J. Med. Chem.";"2016";"CHEMBL3307634";""
"CHEMBL23254";"PURVALANOL B";"0";"432.91";"0";"3.93";"Purvalanol B";"CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(=O)O)c(Cl)c2)c2ncn(C(C)C)c2n1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"18.38";"0.36";"4.03";"6.36";"0";"CHEMBL3225462";"Inhibition of TrkB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217685";"1";"Scientific Literature";"MedChemComm";"2012";"None";""
"CHEMBL3673449";"";"0";"473.58";"0";"4.00";"BDBM164898";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CCC(N)CC5)ccc43)cc2OC)cn1";"IC50";"'='";"637.0";"nM";"6.20";"";"308457";"UO_0000065";"13.08";"0.24";"2.20";"7.07";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3582438";"";"0";"383.43";"0";"4.75";"13";"N#Cc1ccc(-c2cnc3ccc(N4CCC[C@@H]4c4cccc(F)c4)nn23)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"20.76";"0.37";"3.21";"13.91";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL4439123";"";"0";"424.43";"1";"6.01";"L365-0058";"O=C(Nc1ccc(CCc2nc3ccccc3[nH]2)cc1)Nc1cccc(C(F)(F)F)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.07";"0.21";"-1.31";"6.73";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4439176";"";"0";"416.48";"1";"5.01";"L365-0018";"COc1ccc(OC)c(NC(=O)Nc2ccc(CCc3nc4ccccc4[nH]3)cc2)c1";"IC50";"'='";"9064.5";"nM";"5.04";"";"";"UO_0000065";"12.11";"0.22";"0.03";"5.71";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4444901";"";"0";"484.56";"0";"3.81";"1a; G755-0543";"COc1ccc(OC)c(NC(=O)Nc2nnc(SCc3cc(=O)n4cc(C)ccc4n3)s2)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.70";"0.19";"0.89";"3.92";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4558796";"";"0";"416.48";"1";"5.01";"L365-0056";"COc1ccc(NC(=O)Nc2ccc(CCc3nc4ccccc4[nH]3)cc2)c(OC)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.28";"0.21";"-0.31";"5.32";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL3673446";"";"0";"459.55";"0";"4.97";"BDBM164895";"COc1ccc(COc2ccc(Cn3cnc4cc(C5CCOCC5)ccc43)cc2OC)cn1";"IC50";"'='";"257.0";"nM";"6.59";"";"308454";"UO_0000065";"14.34";"0.26";"1.62";"9.74";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1162963";"";"0";"515.62";"1";"4.81";"3";"CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL887039";"Inhibition of human TrkB";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139192";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2007";"None";""
"CHEMBL4210892";"";"0";"521.47";"1";"3.04";"10b";"Cn1cnc(-c2cnc(O[C@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@H]3F)c(C(N)=O)c2)c1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"16.46";"0.32";"5.55";"7.63";"0";"CHEMBL4195800";"Antagonist activity at prolink-tagged TrkB in human U2OS cells assessed as inhibition of BDNF-induced receptor phosphorylation by measuring reduction in EA-tagged SH2 protein recruitment preincubated for 30 mins followed by BDNF stimulation measured after 2 hrs by PathHunter enzyme complementation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190406";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL3741589";"";"0";"366.24";"0";"4.09";"29; A-971432";"O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3743940";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739276";"1";"Scientific Literature";"J. Med. Chem.";"2015";"None";""
"CHEMBL4215846";"";"0";"502.49";"1";"3.70";"3";"Cn1cnc(-c2ccc(OC3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3)c(C(N)=O)c2)c1";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"16.35";"0.31";"4.51";"8.24";"0";"CHEMBL4195800";"Antagonist activity at prolink-tagged TrkB in human U2OS cells assessed as inhibition of BDNF-induced receptor phosphorylation by measuring reduction in EA-tagged SH2 protein recruitment preincubated for 30 mins followed by BDNF stimulation measured after 2 hrs by PathHunter enzyme complementation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190406";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4208510";"";"0";"503.48";"1";"3.09";"15";"Cn1cc(-c2ccc(OC3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3)c(C(N)=O)n2)cn1";"IC50";"'='";"6.6";"nM";"8.18";"";"";"UO_0000065";"16.25";"0.31";"5.09";"7.27";"0";"CHEMBL4195800";"Antagonist activity at prolink-tagged TrkB in human U2OS cells assessed as inhibition of BDNF-induced receptor phosphorylation by measuring reduction in EA-tagged SH2 protein recruitment preincubated for 30 mins followed by BDNF stimulation measured after 2 hrs by PathHunter enzyme complementation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190406";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4203637";"";"0";"489.45";"0";"2.70";"16a";"Cn1cc(-c2ccc(O[C@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C3)c(C(N)=O)n2)cn1";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"12.35";"0.24";"3.35";"5.37";"0";"CHEMBL4195800";"Antagonist activity at prolink-tagged TrkB in human U2OS cells assessed as inhibition of BDNF-induced receptor phosphorylation by measuring reduction in EA-tagged SH2 protein recruitment preincubated for 30 mins followed by BDNF stimulation measured after 2 hrs by PathHunter enzyme complementation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190406";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4203759";"";"0";"528.50";"1";"3.39";"13b";"CC(C)(O)COc1ccc(C(N)=O)c(O[C@H]2CCN(C(=O)Cc3ccc(OC(F)(F)F)cc3)C[C@H]2F)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"14.80";"0.29";"4.43";"7.03";"0";"CHEMBL4195800";"Antagonist activity at prolink-tagged TrkB in human U2OS cells assessed as inhibition of BDNF-induced receptor phosphorylation by measuring reduction in EA-tagged SH2 protein recruitment preincubated for 30 mins followed by BDNF stimulation measured after 2 hrs by PathHunter enzyme complementation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190406";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL3671311";"";"0";"542.54";"1";"4.04";"BDBM130912";"C[C@@H](Cc1c(F)c(F)cc(F)c1F)Nc1cc[nH]c(=O)c1-c1nc2cc3c(cc2[nH]1)CN(CCN(C)C)C3=O";"IC50";"'='";"2.064";"nM";"8.69";"";"263061";"UO_0000065";"16.01";"0.30";"4.65";"8.94";"0";"CHEMBL3707732";"In Vitro Kinase Activity Assay: Compounds to be tested were dissolved in 100% DMSO in a range of concentrations from 10-8 to 10-3 M including negative control (DMSO), then diluted with Kinase Buffer (50 mM HEPES, pH 7.5, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, and 2 mM DTT, added fresh) to 4x the final concentration. The final curve included 11 concentrations (10-11 to 10-5 M) plus negative control DMSO tested in triplicate.Kinase and ATP concentrations necessary for optimal activity were determined in separate experiments. (Table 2). Briefly, increasing concentrations of kinase were incubated in a fixed concentration of ATP (200 uM) in Kinase Buffer to determine maximal activity at various time points (30-120 min). The concentration of kinase that resulted in maximal activity with the shortest incubation time was then incubated in Kinase Buffer with increasing concentrations of ATP.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639188";"37";"BindingDB Database";"";"2014";"None";""
"CHEMBL3582433";"";"0";"397.44";"0";"2.79";"7";"NS(=O)(=O)c1ccc(-c2cnc3ccc(NCc4cccc(F)c4)nn23)cc1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"19.84";"0.38";"5.10";"7.70";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL3582427";"";"0";"325.38";"0";"3.88";"1";"N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"20.19";"0.36";"2.69";"9.95";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL2037221";"";"0";"728.82";"2";"6.35";"17";"CCN(CC)CCNC(=O)c1c[nH]c(/C=C2\C(=O)Nc3cc(Nc4cccc(NC(=O)c5cc(N6CCN(C)CC6)cc(C(F)(F)F)c5)c4)ccc32)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"10.59";"0.20";"1.37";"6.18";"0";"CHEMBL2038861";"Inhibition of TRKB by HTRF assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034853";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2012";"None";""
"CHEMBL4446806";"";"0";"435.33";"1";"5.75";"L365-0036";"O=C(Nc1ccc(Br)cc1)Nc1ccc(CCc2nc3ccccc3[nH]2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.79";"0.23";"-1.05";"6.73";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4558108";"";"0";"496.57";"0";"3.97";"G755-0444";"CCOC(=O)c1ccccc1NC(=O)Nc1nnc(SCc2cc(=O)n3ccc(C)cc3n2)s1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.07";"0.20";"1.03";"3.92";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4542337";"";"0";"412.54";"1";"6.10";"L365-0778";"CCn1c(CCc2ccc(NC(=O)Nc3ccc(C)cc3C)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.39";"0.21";"-1.40";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4447061";"";"0";"452.57";"0";"4.41";"G755-0338";"Cc1ccc(C)c(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)c1";"IC50";"'='";"2138.5";"nM";"5.67";"";"";"UO_0000065";"12.53";"0.25";"1.26";"5.60";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4469679";"";"0";"424.51";"0";"4.02";"L785-0027";"Cc1ccc(NC(=O)Nc2nnc(SCc3nc4ccccc4[nH]c3=O)s2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.07";"0.22";"0.68";"4.17";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4564272";"";"0";"438.54";"0";"4.10";"G755-0351";"Cc1cccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)c1";"IC50";"'='";"9792.4";"nM";"5.01";"";"";"UO_0000065";"11.42";"0.23";"0.91";"4.95";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL3673462";"";"0";"525.61";"1";"4.26";"BDBM164911";"COc1ccc(COc2ccc(Cn3cnc4cc(-c5cnn(C6CCNCC6)c5)cnc43)cc2OC)cn1";"IC50";"'='";"0.9";"nM";"9.05";"";"308470";"UO_0000065";"17.21";"0.32";"4.79";"8.94";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673483";"";"0";"471.52";"0";"3.45";"BDBM164934";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5ccn(C)n5)cnc43)cc2OC)cn1";"IC50";"'='";"2.0";"nM";"8.70";"";"308493";"UO_0000065";"18.45";"0.34";"5.25";"7.56";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3582441";"";"0";"501.57";"1";"3.48";"16";"O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"17.94";"0.33";"5.52";"9.99";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL3582435";"";"0";"399.43";"0";"3.98";"10";"N#Cc1ccc(-c2cnc3ccc(N4CCOCC4c4cccc(F)c4)nn23)cc1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"18.35";"0.33";"3.35";"11.03";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL1929238";"";"0";"554.54";"2";"5.23";"27";"CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O";"IC50";"'='";"8700.0";"nM";"5.06";"";"";"UO_0000065";"9.13";"0.19";"-0.17";"5.95";"0";"CHEMBL1931567";"Inhibition of TRKB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1926590";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2011";"None";""
"CHEMBL4097246";"";"0";"478.48";"0";"4.73";"L785-0049";"O=C(Nc1cccc(C(F)(F)F)c1)Nc1nnc(SCc2nc3ccccc3[nH]c2=O)s1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.82";"0.20";"-0.03";"4.17";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4588390";"";"0";"438.54";"0";"4.10";"G755-0326";"Cc1ccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.40";"0.23";"0.90";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4466061";"";"0";"452.57";"0";"4.35";"G755-0333";"CCc1ccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.38";"0.21";"0.35";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4458705";"";"0";"492.51";"0";"4.81";"G755-0452";"Cc1ccn2c(=O)cc(CSc3nnc(NC(=O)Nc4ccccc4C(F)(F)F)s3)nc2c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.54";"0.19";"-0.11";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4590914";"";"0";"448.95";"1";"6.15";"L365-0756";"CCn1c(CCc2ccc(NC(=O)Nc3cc(Cl)ccc3OC)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.47";"0.20";"-1.45";"6.89";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4574513";"";"0";"442.50";"0";"3.93";"G755-0368";"Cc1cccn2c(=O)cc(CSc3nnc(NC(=O)Nc4ccc(F)cc4)s3)nc12";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.62";"0.21";"0.77";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4453384";"";"0";"452.57";"0";"4.41";"G755-0330";"Cc1ccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)cc1C";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.38";"0.21";"0.29";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4573890";"";"0";"468.56";"0";"4.11";"G755-0360";"COc1ccc(C)cc1NC(=O)Nc1nnc(SCc2cc(=O)n3cccc(C)c3n2)s1";"IC50";"'='";"358.6";"nM";"6.45";"";"";"UO_0000065";"13.76";"0.28";"2.34";"5.83";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4570112";"";"0";"456.53";"0";"4.24";"G755-0554";"Cc1ccc2nc(CSc3nnc(NC(=O)Nc4ccc(C)c(F)c4)s3)cc(=O)n2c1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.95";"0.22";"0.76";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4589373";"";"0";"613.67";"2";"5.64";"88; KST016366";"CCN1CCN(Cc2ccc(NC(=O)Nc3nc4ccc(Oc5ccnc(C(=O)NC)c5)cc4s3)cc2C(F)(F)F)CC1";"IC50";"'='";"4.42";"nM";"8.36";"";"";"UO_0000065";"13.61";"0.27";"2.71";"7.48";"0";"CHEMBL4349460";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL3582430";"";"0";"355.40";"0";"3.89";"4";"COc1ccccc1CNc1ccc2ncc(-c3ccc(C#N)cc3)n2n1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"19.47";"0.35";"3.03";"9.20";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL4549982";"";"0";"452.44";"0";"4.32";"9";"Nc1nn2cc(N3CCC[C@@H]3c3cc(F)ccc3F)cnc2c1C(=O)Nc1ccc(F)cc1";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4349456";"Inhibition of N- terminal GST-tagged human TRKB cytoplasmic domain (456 to 822 end residues) expressed in baculovirus expression system using TK peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4739922";"";"0";"477.83";"0";"3.90";"3; ASN 7186636";"COc1ccc(-n2ncc3c(=O)n(CC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cnc32)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4716029";"Inhibition of human TRKB by FLIPR assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715685";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";""
"CHEMBL1090360";"";"0";"587.71";"2";"6.28";"26";"O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1109702";"Inhibition of TrkB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156213";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"None";""
"CHEMBL4791998";"";"0";"443.91";"0";"2.24";"36";"Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1";"IC50";"'='";"2.04";"nM";"8.69";"";"";"UO_0000065";"21.33";"0.40";"6.45";"11.14";"0";"CHEMBL4768798";"Inhibition of human TrkB in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765285";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";""
"CHEMBL460702";"BMS-777607";"2";"512.90";"2";"5.19";"10, BMS-777607";"CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"13.10";"0.25";"1.53";"6.20";"0";"CHEMBL957093";"Inhibition of TrkB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140952";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL4558824";"";"0";"390.87";"1";"5.65";"L365-0004";"O=C(Nc1ccc(CCc2nc3ccccc3[nH]2)cc1)Nc1cccc(Cl)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"12.02";"0.23";"-0.95";"6.73";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4558719";"";"0";"472.98";"0";"4.75";"G755-0716";"Cc1ccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cc(Cl)ccc4n3)s2)cc1C";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.57";"0.22";"0.25";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4448292";"";"0";"482.55";"0";"3.58";"G755-0337";"COC(=O)c1ccccc1NC(=O)Nc1nnc(SCc2cc(=O)n3cccc(C)c3n2)s1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.74";"0.19";"1.12";"3.68";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4515809";"";"0";"414.47";"0";"4.31";"17";"CC(C)c1cc(C(=O)c2cccc(NC(=O)Nc3ccccc3)c2)c2c(N)ncnn12";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4349460";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL58905";"";"0";"415.25";"0";"4.43";"30";"COc1ccc(Nc2nc(Nc3ccc(C(=O)O)cc3)ncc2Br)cc1";"IC50";"'='";"646.0";"nM";"6.19";"";"";"UO_0000065";"14.91";"0.33";"1.76";"6.42";"0";"CHEMBL1003981";"Inhibition of human TrkB expressed in Sf9 cells by homogeneous time-resolved fluorescence technology";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155933";"1";"Scientific Literature";"J. Med. Chem.";"2008";"CHEMBL3308860";""
"CHEMBL288441";"BOSUTINIB";"4";"530.46";"2";"5.19";"SKI-606";"COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"14.27";"0.29";"2.38";"9.13";"0";"CHEMBL1244592";"Inhibition of TRKB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240341";"1";"Scientific Literature";"Leukemia";"2009";"None";""
"CHEMBL2037218";"";"0";"611.63";"2";"6.15";"14";"CN1CCN(c2cc(C(=O)Nc3cccc(Nc4ccc5c(c4)NC(=O)/C5=C\c4cc(C#N)c[nH]4)c3)cc(C(F)(F)F)c2)CC1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"12.37";"0.23";"1.42";"6.51";"0";"CHEMBL2038861";"Inhibition of TRKB by HTRF assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034853";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2012";"None";""
"CHEMBL214329";"";"0";"390.54";"0";"4.43";"2";"CN1CCN(c2ccc(Nc3ncc4ccn(C5CCCCC5)c4n3)cc2)CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"17.40";"0.32";"2.37";"13.81";"0";"CHEMBL873757";"Inhibition of TrkB";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137238";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2006";"None";""
"CHEMBL2037211";"";"0";"586.62";"2";"6.27";"7";"CN1CCN(c2cc(C(=O)Nc3cccc(Nc4ccc5c(c4)NC(=O)/C5=C\c4ccc[nH]4)c3)cc(C(F)(F)F)c2)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"13.90";"0.26";"1.88";"8.82";"0";"CHEMBL2038861";"Inhibition of TRKB by HTRF assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034853";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2012";"None";""
"CHEMBL4066664";"";"0";"348.29";"0";"3.82";"8";"FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12";"IC50";"'='";"5240.0";"nM";"5.28";"";"";"UO_0000065";"15.16";"0.29";"1.46";"5.76";"0";"CHEMBL4007753";"Inhibition of TrkB (unknown origin) after 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007384";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL590109";"";"0";"425.52";"0";"4.40";"31a";"NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1073314";"Inhibition of TRKB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153138";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"None";""
"CHEMBL3889654";"LAROTRECTINIB";"4";"428.44";"0";"2.95";"17; ARRY-470";"O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"17.78";"0.34";"4.67";"8.86";"0";"CHEMBL3861739";"Inhibition of TrkB (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3860101";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4469569";"";"0";"392.33";"1";"5.61";"40";"Cc1ccc(NC(=O)c2ccc(C(F)(F)F)cc2F)c(-c2ccc(F)cc2)n1";"IC50";"'='";"27000.0";"nM";"4.57";"";"";"UO_0000065";"11.64";"0.22";"-1.04";"10.88";"0";"CHEMBL4330192";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330054";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3545365";"ALTIRATINIB";"1";"510.47";"1";"5.00";"25; DCC2701";"O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"16.33";"0.31";"3.34";"7.62";"0";"CHEMBL4330192";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330054";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3989926";"SITRAVATINIB";"3";"629.69";"2";"6.52";"24; MGCD516";"COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)cc4F)c3s2)nc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"12.78";"0.24";"1.53";"7.03";"0";"CHEMBL4330192";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330054";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4438225";"";"0";"548.57";"1";"4.16";"9f";"COc1c(C#Cc2cnc3cnccn23)cccc1C(=O)Nc1cc(CN2CCN(C)CC2)cc(C(F)(F)F)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4218103";"";"0";"503.48";"1";"4.16";"1";"Cn1cc(-c2ccc(OC3CCN(C(=O)Nc4ccc(OC(F)(F)F)cc4)CC3)c(C(N)=O)c2)cn1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"14.97";"0.29";"3.38";"6.75";"0";"CHEMBL4195800";"Antagonist activity at prolink-tagged TrkB in human U2OS cells assessed as inhibition of BDNF-induced receptor phosphorylation by measuring reduction in EA-tagged SH2 protein recruitment preincubated for 30 mins followed by BDNF stimulation measured after 2 hrs by PathHunter enzyme complementation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190406";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL3582440";"";"0";"458.54";"0";"4.23";"15";"OC1CCN(c2cccc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)n2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"18.31";"0.34";"4.17";"12.03";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL3582431";"";"0";"348.38";"0";"3.64";"5";"OCc1ccc(-c2cnc3ccc(NCc4cccc(F)c4)nn23)cc1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"21.73";"0.40";"3.93";"12.12";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL3582428";"";"0";"325.38";"0";"3.88";"2";"N#Cc1cccc(-c2cnc3ccc(NCc4ccccc4)nn23)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"20.59";"0.37";"2.82";"10.15";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL2403108";"CERITINIB";"4";"558.15";"2";"6.36";"15b, LDK378";"Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1";"IC50";"'='";"1829.0";"nM";"5.74";"";"";"UO_0000065";"10.28";"0.21";"-0.62";"5.45";"0";"CHEMBL2405533";"Inhibition of TEL-fused TRKB (unknown origin) by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401692";"1";"Scientific Literature";"J. Med. Chem.";"2013";"None";""
"CHEMBL2037213";"";"0";"587.60";"2";"6.48";"9";"O=C1Nc2cc(Nc3cccc(NC(=O)c4cc(N5CCC(O)CC5)cc(C(F)(F)F)c4)c3)ccc2/C1=C/c1ccc[nH]1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"12.29";"0.23";"0.74";"6.60";"0";"CHEMBL2038861";"Inhibition of TRKB by HTRF assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034853";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2012";"None";""
"CHEMBL518051";"";"0";"527.05";"0";"4.52";"21, SNS-314";"CS(=O)(=O)O.O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"19.26";"0.40";"3.78";"8.73";"0";"CHEMBL972596";"Inhibition of TrkB by radiometric assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156726";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2008";"None";""
"CHEMBL601719";"CRIZOTINIB";"4";"450.35";"1";"5.04";"14, PF-2341066";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"IC50";"'='";"399.0";"nM";"6.40";"";"";"UO_0000065";"14.21";"0.29";"1.36";"8.20";"0";"CHEMBL990567";"Inhibition of TrkB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149823";"1";"Scientific Literature";"Proc. Natl. Acad. Sci. U.S.A.";"2007";"None";""
"CHEMBL497854";"";"0";"390.25";"0";"3.49";"5";"Cc1cc(CNc2ncc(Br)c(Nc3cc(C4CC4)[nH]n3)n2)on1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"15.27";"0.34";"2.47";"5.70";"0";"CHEMBL1003981";"Inhibition of human TrkB expressed in Sf9 cells by homogeneous time-resolved fluorescence technology";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155933";"1";"Scientific Literature";"J. Med. Chem.";"2008";"CHEMBL3308860";""
"CHEMBL4437631";"";"0";"492.51";"0";"4.85";"7f";"Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C(F)(F)F)c2)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3128069";"";"0";"470.53";"0";"3.16";"8e";"Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"17.85";"0.35";"5.24";"6.35";"0";"CHEMBL3129259";"Inhibition of NTRK2 (unknown origin) using Km levels of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124869";"1";"Scientific Literature";"J. Med. Chem.";"2014";"None";""
"CHEMBL4452210";"";"0";"412.54";"1";"6.10";"L365-0753";"CCn1c(CCc2ccc(NC(=O)Nc3cc(C)cc(C)c3)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.39";"0.21";"-1.40";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4451409";"";"0";"412.54";"1";"6.10";"L365-0751";"CCn1c(CCc2ccc(NC(=O)Nc3ccc(C)c(C)c3)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.39";"0.21";"-1.40";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4580964";"";"0";"424.51";"0";"3.79";"G755-0327";"Cc1cccn2c(=O)cc(CSc3nnc(NC(=O)Nc4ccccc4)s3)nc12";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.07";"0.22";"0.91";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4474629";"";"0";"388.45";"1";"5.44";"L365-0050";"Cc1ccc(NC(=O)Nc2ccc(CCc3nc4ccccc4[nH]3)cc2)cc1F";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"12.10";"0.22";"-0.74";"6.73";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4444056";"";"0";"452.57";"0";"4.41";"G755-0334";"Cc1cccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)c1C";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.05";"0.22";"0.59";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4563845";"";"0";"438.45";"1";"6.02";"L365-1424";"Cn1c(CCc2ccc(NC(=O)Nc3ccccc3C(F)(F)F)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.72";"0.20";"-1.32";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4463148";"";"0";"424.51";"0";"3.79";"G755-0235";"Cc1ccccc1NC(=O)Nc1nnc(SCc2cc(=O)n3ccccc3n2)s1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.07";"0.22";"0.91";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL2151321";"";"0";"381.42";"0";"3.64";"2c";"CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2154719";"Inhibition of TrkB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150905";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2012";"None";""
"CHEMBL4441609";"";"0";"466.59";"0";"4.95";"7k";"Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C(C)C)c2)cn1";"IC50";"'='";"145.4";"nM";"6.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4560079";"";"0";"506.65";"2";"5.87";"7m";"Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C3CCCCC3)c2)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4445789";"";"0";"484.56";"0";"3.81";"G755-0458";"COc1cc(NC(=O)Nc2nnc(SCc3cc(=O)n4ccc(C)cc4n3)s2)cc(OC)c1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.32";"0.21";"1.19";"4.18";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4467067";"";"0";"454.54";"0";"3.80";"G755-0547";"COc1ccccc1NC(=O)Nc1nnc(SCc2cc(=O)n3cc(C)ccc3n2)s1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.00";"0.22";"1.20";"4.52";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4454652";"";"0";"472.98";"0";"4.75";"G755-0335";"Cc1ccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)cc1Cl";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.57";"0.22";"0.25";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4555442";"";"0";"399.45";"0";"3.12";"17c";"Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"24.28";"0.47";"6.58";"10.47";"0";"CHEMBL4349746";"Inhibition of human GST-tagged TRKB (456 to 822) expressed in baculovirus expression system using TK-biotin peptide as substrate incubated for 45 min by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346729";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";""
"CHEMBL3582437";"";"0";"383.43";"0";"4.75";"12";"N#Cc1ccc(-c2cnc3ccc(N4CCC[C@H]4c4cccc(F)c4)nn23)cc1";"IC50";"'='";"1970.0";"nM";"5.71";"";"";"UO_0000065";"14.88";"0.27";"0.96";"9.97";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL2037226";"";"0";"535.50";"2";"7.36";"22, GNF-5837";"Cc1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"14.79";"0.28";"0.56";"8.08";"0";"CHEMBL2038861";"Inhibition of TRKB by HTRF assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034853";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2012";"None";""
"CHEMBL1834657";"INFIGRATINIB PHOSPHATE";"4";"658.48";"2";"5.35";"1h, NVP-BGJ398";"CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O";"IC50";"'='";"3139.0";"nM";"5.50";"";"";"UO_0000065";"9.82";"0.20";"0.15";"5.79";"0";"CHEMBL1839969";"Inhibition of TRKB juxtamembrane domain-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833940";"1";"Scientific Literature";"J. Med. Chem.";"2011";"CHEMBL3307634";""
"CHEMBL103667";"DORAMAPIMOD";"2";"527.67";"2";"5.99";"2, BIRB-796";"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"13.84";"0.26";"1.31";"9.05";"0";"CHEMBL1931567";"Inhibition of TRKB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1926590";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2011";"None";""
"CHEMBL3673474";"";"0";"498.58";"0";"4.26";"BDBM164925";"COc1ccc(COc2ccc(Cn3cnc4cc(C5=CC6(O)CCCN5C6)ccc43)cc2OC)cn1";"IC50";"'='";"372.0";"nM";"6.43";"";"308484";"UO_0000065";"12.90";"0.24";"2.17";"7.85";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673451";"";"0";"502.58";"1";"2.94";"BDBM164900";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(N5CCN(C)CC5=O)ccc43)cc2OC)cn1";"IC50";"'='";"4370.0";"nM";"5.36";"";"308459";"UO_0000065";"10.66";"0.20";"2.42";"4.96";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678286";"";"0";"522.53";"2";"5.15";"BDBM164944";"COc1cc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(CC(F)(F)F)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"308503";"UO_0000065";"18.22";"0.34";"4.37";"10.24";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4446681";"";"0";"491.61";"1";"6.91";"27";"CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"10.58";"0.19";"-1.71";"13.95";"0";"CHEMBL4340722";"Inhibition of recombinant human N-terminal GST-His6-fused TRKB C-terminal domain (V526 to G838 residues) expressed in Sf9 insect cells using Poly(Glu:Tyr)4:1 as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340507";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";""
"CHEMBL4554856";"";"0";"417.87";"0";"3.45";"11";"CC(C)N1Cc2cc(cc(F)c2Cl)O[C@@H](C)CNC(=O)c2cnn3cc1cnc23";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"13.94";"0.27";"2.37";"8.12";"0";"CHEMBL4349460";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL3678289";"";"0";"459.51";"0";"2.79";"BDBM164947";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(C#CCCO)cnc43)cc2OC)cn1";"IC50";"'='";"3.0";"nM";"8.52";"";"308506";"UO_0000065";"18.55";"0.34";"5.73";"7.25";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678295";"";"0";"507.52";"2";"6.05";"BDBM164953";"COc1cc(C(C)n2cnc3cc(-c4cnn(C)c4)ccc32)ccc1OCc1ccc(C(F)(F)F)nc1";"IC50";"'='";"14.0";"nM";"7.85";"";"308512";"UO_0000065";"15.47";"0.29";"1.80";"11.72";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673470";"";"0";"487.56";"0";"3.35";"BDBM164921";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CCN(C)CC5=O)ccc43)cc2OC)cn1";"IC50";"'='";"4280.0";"nM";"5.37";"";"308480";"UO_0000065";"11.01";"0.20";"2.02";"6.55";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673475";"";"0";"499.58";"0";"4.40";"BDBM164926";"CCC(Oc1ccc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)cc1OC)c1ccc(OC)nc1";"IC50";"'='";"26.0";"nM";"7.58";"";"308485";"UO_0000065";"15.18";"0.28";"3.19";"6.59";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673480";"";"0";"461.55";"0";"3.81";"BDBM164931";"COc1cc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1csc(C)n1";"IC50";"'='";"0.2";"nM";"9.70";"";"308490";"UO_0000065";"21.01";"0.40";"5.89";"9.16";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673437";"";"0";"467.53";"0";"4.72";"BDBM164886";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cncnc5)ccc43)cc2OC)cc1";"IC50";"'='";"23.0";"nM";"7.64";"";"308445";"UO_0000065";"16.34";"0.30";"2.92";"7.85";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673438";"";"0";"466.54";"1";"5.33";"BDBM164887";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5ccncc5)ccc43)cc2OC)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"308446";"UO_0000065";"18.00";"0.33";"3.07";"9.95";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673453";"";"0";"543.56";"1";"4.97";"BDBM164902";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5ccc(P(C)(C)=O)nc5)cnc43)cc2OC)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"308461";"UO_0000065";"17.84";"0.34";"4.73";"8.48";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673457";"";"0";"500.60";"1";"3.76";"BDBM164906";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CCN(C6CC6)CC5)cnc43)cc2OC)cn1";"IC50";"'='";"52.0";"nM";"7.28";"";"308465";"UO_0000065";"14.55";"0.27";"3.52";"9.37";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673459";"";"0";"500.60";"1";"3.66";"BDBM164908";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CC6(CCNCC6)C5)cnc43)cc2OC)cn1";"IC50";"'='";"21.0";"nM";"7.68";"";"308467";"UO_0000065";"15.34";"0.28";"4.02";"8.87";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673464";"";"0";"527.59";"2";"3.99";"BDBM164913";"COc1ccc(COc2ccc(Cn3cnc4cc(-c5noc(C6CCNCC6)n5)cnc43)cc2OC)cn1";"IC50";"'='";"24.0";"nM";"7.62";"";"308472";"UO_0000065";"14.44";"0.27";"3.63";"6.23";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673467";"";"0";"500.56";"2";"3.25";"BDBM164916";"COc1ccc(COc2ccc(Cn3cnc4cc(-n5cc(C(C)(C)N)nn5)cnc43)cc2OC)cn1";"IC50";"'='";"43.0";"nM";"7.37";"";"308475";"UO_0000065";"14.72";"0.27";"4.12";"5.75";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673477";"";"0";"509.49";"1";"4.46";"BDBM164928";"COc1cc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(C(F)(F)F)nc1";"IC50";"'='";"0.2";"nM";"9.70";"";"308487";"UO_0000065";"19.04";"0.36";"5.24";"9.16";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678287";"";"0";"515.52";"1";"4.53";"BDBM164945";"COc1cc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1csc(C(F)(F)F)n1";"IC50";"'='";"0.2";"nM";"9.70";"";"308504";"UO_0000065";"18.81";"0.37";"5.17";"9.16";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1707321";"";"0";"368.46";"0";"4.39";"Z15486439";"CC(C)(C)c1ccc(NC(=O)COC(=O)c2ccc3ncsc3c2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"12.75";"0.25";"0.31";"6.88";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL3639723";"";"0";"488.59";"0";"3.41";"BDBM164918";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(N5CCN(C)CC5)ccc43)cc2OC)cn1";"IC50";"'='";"315.0";"nM";"6.50";"";"308477";"UO_0000065";"13.31";"0.25";"3.09";"7.15";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3930625";"";"0";"522.61";"2";"5.94";"25";"O=C(O)c1ccc(Nc2cc(N3CCN(C4CCCCC4)CC3)c3noc4c3c2C(=O)c2ccccc2-4)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3861749";"Inhibition of BDNF-stimulated TrkB phosphorylation in human U2OS cells by beta-galactosidase reporter gene based PathHunter profiling assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3860101";"1";"Scientific Literature";"J Med Chem";"2017";"CHEMBL3307757";""
"CHEMBL3355065";"";"0";"454.50";"0";"4.13";"7";"CNc1cc2ccc(C#CCOc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2cn1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"14.79";"0.28";"2.59";"13.60";"0";"CHEMBL3379616";"Inhibition of NTRK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352215";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"None";""
"CHEMBL2436978";"";"0";"421.55";"1";"5.13";"1, URMC-099";"CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1";"IC50";"'='";"217.0";"nM";"6.66";"";"";"UO_0000065";"15.81";"0.28";"1.53";"13.08";"0";"CHEMBL2439150";"Inhibition of wild type human TRKB by high throughput ATP-[33P] radiolabeled assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434948";"1";"Scientific Literature";"J. Med. Chem.";"2013";"None";""
"CHEMBL3673436";"";"0";"469.55";"0";"4.66";"24";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cnn(C)c5)ccc43)cc2OC)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"20.28";"0.37";"4.86";"10.66";"0";"CHEMBL3861746";"Inhibition of N-terminal GST tagged human TrkB cytoplasmic domain (456 to 822 amino acids) pre-incubated for 15 mins before peptide substrate addition for 180 mins by fluorescence based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3860101";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3678296";"";"0";"495.50";"1";"5.38";"BDBM164954";"COc1cc(C(C)n2cnc3cc(C#CCCO)ccc32)ccc1OCc1ccc(C(F)(F)F)nc1";"IC50";"'='";"127.0";"nM";"6.90";"";"308513";"UO_0000065";"13.92";"0.26";"1.52";"9.94";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL509032";"TAE-684";"0";"614.22";"2";"5.02";"12, NVP-TAE684";"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1";"IC50";"'='";"2018.0";"nM";"5.70";"";"";"UO_0000065";"9.27";"0.19";"0.68";"5.53";"0";"CHEMBL1006338";"Inhibition of Tel-fused TRKB kinase-mediated mouse BaF3 cell proliferation";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156430";"1";"Scientific Literature";"Proc. Natl. Acad. Sci. U.S.A.";"2007";"CHEMBL3307634";""
"CHEMBL4467427";"";"0";"532.57";"1";"4.46";"9a";"Cc1cc(C#Cc2cnc3cnccn23)cc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)c1";"IC50";"'='";"178.45";"nM";"6.75";"";"";"UO_0000065";"12.67";"0.24";"2.29";"10.26";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4440122";"";"0";"532.57";"1";"4.46";"9b";"Cc1ccc(C#Cc2cnc3cnccn23)cc1C(=O)Nc1cc(CN2CCN(C)CC2)cc(C(F)(F)F)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4446455";"";"0";"569.71";"1";"4.99";"9m";"Cc1cc(CN2CCN(C)CC2)cc(NC(=O)c2cccc(C#Cc3cnc4cnc(-c5ccc(N)cc5)cn34)c2C)c1";"IC50";"'='";"41.34";"nM";"7.38";"";"";"UO_0000065";"12.96";"0.23";"2.39";"8.04";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4584949";"";"0";"539.54";"2";"6.16";"23a";"Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21";"IC50";"'='";"58.8";"nM";"7.23";"";"";"UO_0000065";"13.40";"0.25";"1.07";"7.37";"0";"CHEMBL4376520";"Inhibition of recombinant human His-tagged TRKB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373740";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";""
"CHEMBL4447685";"";"0";"445.48";"0";"2.94";"2a; Z25180415";"CC(C)(C)c1cc(NC(=O)COC(=O)c2ccc(-n3cnnn3)cc2)n(-c2ccccc2)n1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.55";"0.19";"1.76";"4.02";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4471969";"";"0";"473.61";"0";"4.89";"Z92534864";"CC(C)(C)c1cc(NC(=O)CSc2nnc(-c3cccnc3)n2C2CC2)n(-c2ccccc2)n1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.92";"0.19";"-0.19";"5.19";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4473447";"";"0";"373.37";"0";"2.61";"Z25180998";"O=C(COC(=O)c1ccc(-n2cnnn2)cc1)Nc1ccc2ccccc2c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"12.59";"0.23";"2.09";"4.75";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4535656";"";"0";"353.30";"0";"2.99";"Z25262807";"O=C(COC(=O)c1ccc(CO)cc1)Nc1cccc(C(F)(F)F)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"13.30";"0.26";"1.71";"6.21";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL3745885";"";"0";"467.46";"0";"3.66";"7ao; ON1231320";"Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3750189";"Inhibition of human TRKB using poly[Glu:Tyr] (4:1) as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745707";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2016";"None";""
"CHEMBL4062803";"";"0";"320.36";"0";"3.73";"19";"Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4007753";"Inhibition of TrkB (unknown origin) after 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007384";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL3582432";"";"0";"445.50";"0";"4.51";"6";"O=C(Nc1ccc(-c2cnc3ccc(NCc4cccc(F)c4)nn23)cc1)C1CCOCC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"18.31";"0.34";"3.64";"10.12";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL3582429";"";"0";"343.37";"0";"4.02";"3";"N#Cc1ccc(-c2cnc3ccc(NCc4cccc(F)c4)nn23)cc1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"22.36";"0.40";"3.66";"11.63";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL4545062";"";"0";"452.57";"0";"4.35";"G755-0533";"CCc1ccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cc(C)ccc4n3)s2)cc1";"IC50";"'='";"2027.5";"nM";"5.69";"";"";"UO_0000065";"12.58";"0.25";"1.34";"5.62";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL3673439";"";"0";"568.68";"1";"4.46";"BDBM164888";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cnn(CCN6CCOCC6)c5)ccc43)cc2OC)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"308447";"UO_0000065";"15.83";"0.29";"4.54";"8.84";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673441";"";"0";"453.50";"0";"4.53";"BDBM164890";"COc1ccc(COc2ccc(Cn3cnc4cc(-c5ccnnc5)ccc43)cc2OC)cn1";"IC50";"'='";"252.0";"nM";"6.60";"";"308449";"UO_0000065";"14.55";"0.27";"2.07";"7.84";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673452";"GZ-389988";"2";"470.53";"0";"4.06";"BDBM164901";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cnn(C)c5)cnc43)cc2OC)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"308460";"UO_0000065";"21.25";"0.39";"5.94";"9.78";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673465";"";"0";"526.60";"1";"4.59";"BDBM164914";"COc1ccc(COc2ccc(Cn3cnc4cc(-c5noc(C6CCNCC6)n5)ccc43)cc2OC)cn1";"IC50";"'='";"317.0";"nM";"6.50";"";"308473";"UO_0000065";"12.34";"0.23";"1.91";"5.94";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4466950";"";"0";"444.54";"1";"5.50";"2b; L365-0757";"CCn1c(CCc2ccc(NC(=O)Nc3cc(OC)ccc3OC)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.57";"0.19";"-0.80";"6.07";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4467309";"";"0";"520.59";"2";"5.89";"18";"CC(C)c1cc(C(=O)c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)c2c(N)ncnn12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"17.29";"0.32";"3.11";"7.28";"0";"CHEMBL4349460";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4547987";"";"0";"414.51";"1";"5.49";"L365-0741";"CCn1c(CCc2ccc(NC(=O)Nc3cccc(OC)c3)cc2)nc2ccccc21";"IC50";"'='";"3224.9";"nM";"5.49";"";"";"UO_0000065";"13.25";"0.24";"0.00";"8.05";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4546610";"";"0";"492.51";"0";"4.81";"G755-0552";"Cc1ccc2nc(CSc3nnc(NC(=O)Nc4ccccc4C(F)(F)F)s3)cc(=O)n2c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.54";"0.19";"-0.11";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4589260";"";"0";"446.51";"1";"5.02";"L365-0041";"COc1cc(NC(=O)Nc2ccc(CCc3nc4ccccc4[nH]3)cc2)cc(OC)c1OC";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.52";"0.19";"-0.32";"4.82";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4440575";"";"0";"428.49";"1";"5.21";"L365-0805";"CCn1c(CCc2ccc(NC(=O)Nc3ccc4c(c3)OCO4)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.97";"0.20";"-0.51";"6.07";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4461600";"";"0";"484.56";"0";"3.81";"G755-0443";"COc1ccc(OC)c(NC(=O)Nc2nnc(SCc3cc(=O)n4ccc(C)cc4n3)s2)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.70";"0.19";"0.89";"3.92";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL1684800";"";"0";"572.98";"2";"6.40";"7c";"COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1687377";"inhibition of TRKB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681781";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2011";"None";""
"CHEMBL3582436";"";"0";"383.43";"0";"4.75";"11";"N#Cc1ccc(-c2cnc3ccc(N4CCCC4c4cccc(F)c4)nn23)cc1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"19.66";"0.35";"2.79";"13.17";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL4443543";"";"0";"492.51";"1";"5.21";"7e";"Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)CC(C)(Nc3cncnc3)C4)cc(C(F)(F)F)c2)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4472004";"";"0";"480.62";"1";"5.12";"7l";"Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C(C)(C)C)c2)cn1";"IC50";"'='";"270.7";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4444653";"";"0";"370.46";"1";"5.30";"L365-0035";"Cc1cccc(NC(=O)Nc2ccc(CCc3nc4ccccc4[nH]3)cc2)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"12.68";"0.23";"-0.60";"6.73";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4545212";"";"0";"438.54";"0";"4.10";"G755-0526";"Cc1ccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cc(C)ccc4n3)s2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.72";"0.21";"0.60";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4529365";"";"0";"404.90";"1";"5.95";"L365-0010";"Cc1ccc(NC(=O)Nc2ccc(CCc3nc4ccccc4[nH]3)cc2)cc1Cl";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.61";"0.22";"-1.25";"6.73";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4468419";"";"0";"478.98";"1";"6.16";"2a; L365-0764";"CCn1c(CCc2ccc(NC(=O)Nc3cc(Cl)c(OC)cc3OC)cc2)nc2ccccc21";"IC50";"'='";"423.2";"nM";"6.37";"";"";"UO_0000065";"13.31";"0.26";"0.21";"8.23";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL2037220";"";"0";"630.63";"2";"5.97";"16";"CN1CCN(c2cc(C(=O)Nc3cccc(Nc4ccc5c(c4)NC(=O)/C5=C\c4cc(C(=O)O)c[nH]4)c3)cc(C(F)(F)F)c2)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"12.32";"0.23";"1.80";"5.99";"0";"CHEMBL2038861";"Inhibition of TRKB by HTRF assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034853";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2012";"None";""
"CHEMBL2037214";"";"0";"616.64";"2";"5.64";"10";"O=C1Nc2cc(Nc3cccc(NC(=O)c4cc(N5CCN(CCO)CC5)cc(C(F)(F)F)c4)c3)ccc2/C1=C/c1ccc[nH]1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"12.09";"0.23";"1.82";"6.61";"0";"CHEMBL2038861";"Inhibition of TRKB by HTRF assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034853";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2012";"None";""
"CHEMBL3580682";"";"0";"339.40";"0";"3.90";"8";"CN(Cc1ccccc1)c1ccc2ncc(-c3ccc(C#N)cc3)n2n1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"20.29";"0.36";"2.99";"12.03";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL4453991";"";"0";"398.51";"1";"5.79";"L365-0759";"CCn1c(CCc2ccc(NC(=O)Nc3ccc(C)cc3)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.79";"0.21";"-1.09";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4579043";"";"0";"428.47";"0";"3.62";"G755-0268";"O=C(Nc1ccc(F)cc1)Nc1nnc(SCc2cc(=O)n3ccccc3n2)s1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.97";"0.22";"1.08";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4562063";"";"0";"438.54";"0";"4.10";"G755-0536";"Cc1ccc2nc(CSc3nnc(NC(=O)Nc4ccccc4C)s3)cc(=O)n2c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.72";"0.21";"0.60";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4520177";"";"0";"404.90";"1";"5.66";"L365-1390";"Cn1c(CCc2ccc(NC(=O)Nc3ccccc3Cl)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.61";"0.22";"-0.96";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4577826";"";"0";"416.55";"1";"5.72";"L365-1456";"CSc1cccc(NC(=O)Nc2ccc(CCc3nc4ccccc4n3C)cc2)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.28";"0.21";"-1.02";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL388978";"STAUROSPORINE";"0";"466.54";"0";"4.35";"staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"17.89";"0.33";"4.00";"12.02";"0";"CHEMBL3225462";"Inhibition of TrkB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217685";"1";"Scientific Literature";"MedChemComm";"2012";"None";""
"CHEMBL4466570";"";"0";"442.50";"0";"3.93";"G755-0331";"Cc1cccn2c(=O)cc(CSc3nnc(NC(=O)Nc4cccc(F)c4)s3)nc12";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.30";"0.23";"1.07";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4456645";"";"0";"430.51";"1";"5.02";"L365-1403";"COc1ccc(OC)c(NC(=O)Nc2ccc(CCc3nc4ccccc4n3C)cc2)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.91";"0.20";"-0.32";"6.07";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL3582439";"";"0";"359.41";"0";"4.27";"14";"Fc1cccc([C@H]2CCCN2c2ccc3ncc(-c4ccccn4)n3n2)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"25.04";"0.46";"4.73";"19.43";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL4437226";"";"0";"484.56";"0";"3.81";"G755-0343";"COc1ccc(OC)c(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)c1";"IC50";"'='";"2497.3";"nM";"5.60";"";"";"UO_0000065";"11.56";"0.23";"1.79";"4.68";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4461532";"";"0";"420.90";"1";"5.65";"L365-0017";"COc1ccc(Cl)cc1NC(=O)Nc1ccc(CCc2nc3ccccc3[nH]2)cc1";"IC50";"'='";"5460.3";"nM";"5.26";"";"";"UO_0000065";"12.50";"0.24";"-0.39";"6.66";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL3582427";"";"0";"325.38";"0";"3.88";"1";"N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"21.76";"0.39";"3.20";"10.73";"0";"CHEMBL3582853";"Inhibition of TRKB (unknown origin) by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"None";""
"CHEMBL3671309";"";"0";"568.58";"1";"4.57";"BDBM130910";"C[C@@H](Cc1c(F)c(F)cc(F)c1F)Nc1cc[nH]c(=O)c1-c1nc2cc3c(cc2[nH]1)CN(C1CCN(C)CC1)C3=O";"IC50";"'='";"3.483";"nM";"8.46";"";"263060";"UO_0000065";"14.88";"0.28";"3.89";"8.71";"0";"CHEMBL3707732";"In Vitro Kinase Activity Assay: Compounds to be tested were dissolved in 100% DMSO in a range of concentrations from 10-8 to 10-3 M including negative control (DMSO), then diluted with Kinase Buffer (50 mM HEPES, pH 7.5, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, and 2 mM DTT, added fresh) to 4x the final concentration. The final curve included 11 concentrations (10-11 to 10-5 M) plus negative control DMSO tested in triplicate.Kinase and ATP concentrations necessary for optimal activity were determined in separate experiments. (Table 2). Briefly, increasing concentrations of kinase were incubated in a fixed concentration of ATP (200 uM) in Kinase Buffer to determine maximal activity at various time points (30-120 min). The concentration of kinase that resulted in maximal activity with the shortest incubation time was then incubated in Kinase Buffer with increasing concentrations of ATP.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639188";"37";"BindingDB Database";"";"2014";"None";""
"CHEMBL4574620";"";"0";"558.73";"2";"6.29";"7n";"Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C34CC5CC(CC(C5)C3)C4)c2)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4553037";"";"0";"492.51";"1";"5.37";"6";"Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)CN(c3cncnc3)C[C@@H]4C)cc(C(F)(F)F)c2)cn1";"IC50";"'='";"36.8";"nM";"7.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4640601";"";"0";"459.55";"0";"4.14";"2";"COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC";"IC50";"'>'";"11000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605821";"Inhibition of TRKB (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602715";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307634";""
"CHEMBL3673460";"";"0";"474.57";"0";"3.40";"BDBM164909";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CCC(N)CC5)cnc43)cc2OC)cn1";"IC50";"'='";"133.0";"nM";"6.88";"";"308468";"UO_0000065";"14.49";"0.27";"3.48";"6.84";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673484";"";"0";"469.51";"0";"3.51";"BDBM164935";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cncnc5)cnc43)cc2OC)cn1";"IC50";"'='";"16.0";"nM";"7.80";"";"308494";"UO_0000065";"16.60";"0.30";"4.29";"6.33";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673466";"";"0";"527.59";"2";"3.99";"BDBM164915";"COc1ccc(COc2ccc(Cn3cnc4cc(-c5nnc(C6CCNCC6)o5)cnc43)cc2OC)cn1";"IC50";"'='";"57.0";"nM";"7.24";"";"308474";"UO_0000065";"13.73";"0.25";"3.25";"5.93";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2010872";"CEP-11981";"2";"477.57";"0";"4.73";"11b, CEP-11981";"CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"17.38";"0.31";"3.57";"9.26";"0";"CHEMBL2016120";"Inhibition of human TRK-B using ATP as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010689";"1";"Scientific Literature";"J. Med. Chem.";"2012";"None";""
"CHEMBL2037223";"";"0";"742.85";"2";"6.57";"19";"Cc1[nH]c(/C=C2\C(=O)Nc3cc(Nc4cccc(NC(=O)c5cc(N6CCN(C)CC6)cc(C(F)(F)F)c5)c4)ccc32)c(C)c1C(=O)NCCCN(C)C";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"10.53";"0.20";"1.25";"6.27";"0";"CHEMBL2038861";"Inhibition of TRKB by HTRF assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034853";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2012";"None";""
"CHEMBL3623375";"";"0";"509.64";"1";"4.67";"19";"CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3624368";"Inhibition of human recombinant TrkB";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621115";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2015";"None";""
"CHEMBL2037209";"";"0";"568.56";"2";"7.02";"90";"Cc1cn(-c2cc(C(=O)Nc3cccc(Nc4ccc5c(c4)NC(=O)/C5=C\c4ccc[nH]4)c3)cc(C(F)(F)F)c2)cn1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"13.81";"0.26";"0.83";"7.56";"0";"CHEMBL4349460";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL3408947";"CFI-400945";"2";"534.66";"2";"5.73";"48";"COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"15.05";"0.27";"2.32";"10.12";"0";"CHEMBL3411676";"Inhibition of TRKB (unknown origin) by FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407349";"1";"Scientific Literature";"J. Med. Chem.";"2015";"None";""
"CHEMBL2171124";"";"0";"451.45";"0";"4.37";"38, GSK2606414";"Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21";"IC50";"'='";"2962.0";"nM";"5.53";"";"";"UO_0000065";"12.25";"0.23";"1.16";"7.18";"0";"CHEMBL2174226";"Inhibition of TRKB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2169840";"1";"Scientific Literature";"J. Med. Chem.";"2012";"None";""
"CHEMBL4457005";"";"0";"483.36";"1";"5.62";"16";"CC(C)c1cc(C(=O)c2cccc(NC(=O)Nc3ccc(Cl)cc3Cl)c2)c2c(N)ncnn12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"18.62";"0.37";"3.38";"7.87";"0";"CHEMBL4349460";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4589669";"";"0";"464.53";"1";"5.46";"19";"CC(C)c1cc(C(=O)c2cccc(NC(=O)Nc3ccc4ccccc4c3)c2)c2c(N)ncnn12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"19.37";"0.35";"3.54";"7.87";"0";"CHEMBL4349460";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL3673440";"";"0";"542.58";"2";"5.57";"BDBM164889";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5ccc(P(C)(C)=O)nc5)ccc43)cc2OC)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"308448";"UO_0000065";"15.15";"0.29";"2.65";"8.10";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673476";"";"0";"471.52";"0";"3.45";"BDBM164927";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cnn(C)c5)cnc43)cc2OC)cn1";"IC50";"'='";"0.3";"nM";"9.52";"";"308486";"UO_0000065";"20.20";"0.37";"6.07";"8.27";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673482";"";"0";"485.52";"0";"4.86";"BDBM164933";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5ccc(F)cc5)cnc43)cc2OC)cn1";"IC50";"'='";"4.0";"nM";"8.40";"";"308492";"UO_0000065";"17.30";"0.32";"3.54";"8.63";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673488";"";"0";"468.52";"0";"4.12";"BDBM164939";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5ccccn5)cnc43)cc2OC)cn1";"IC50";"'='";"2.0";"nM";"8.70";"";"308498";"UO_0000065";"18.57";"0.34";"4.58";"7.89";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678290";"";"0";"511.59";"1";"4.40";"BDBM164948";"COc1ccc(C(Oc2ccc(Cn3c(N)nc4cc(-c5cnn(C)c5)cnc43)cc2OC)C2CC2)cn1";"IC50";"'='";"51.0";"nM";"7.29";"";"308507";"UO_0000065";"14.25";"0.26";"2.89";"6.33";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678302";"";"0";"464.47";"0";"4.13";"BDBM164965";"COc1cc(Cn2cnc3cc(C#CCCO)cnc32)ccc1OCc1ccc(C(F)F)nc1";"IC50";"'='";"4.0";"nM";"8.40";"";"308519";"UO_0000065";"18.08";"0.34";"4.27";"10.21";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4458913";"";"0";"492.51";"0";"4.81";"1b; G755-0559";"Cc1ccc2nc(CSc3nnc(NC(=O)Nc4cccc(C(F)(F)F)c4)s3)cc(=O)n2c1";"IC50";"'='";"9280.0";"nM";"5.03";"";"";"UO_0000065";"10.22";"0.21";"0.22";"4.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4634073";"";"0";"532.60";"1";"4.31";"3";"COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"10.66";"0.20";"1.37";"4.53";"0";"CHEMBL4605821";"Inhibition of TRKB (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602715";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307634";""
"CHEMBL3673455";"";"0";"516.65";"1";"4.42";"BDBM164904";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CCC(C(C)(C)N)CC5)cnc43)cc2OC)cn1";"IC50";"'='";"57.0";"nM";"7.24";"";"308463";"UO_0000065";"14.02";"0.26";"2.82";"7.20";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3545365";"ALTIRATINIB";"1";"510.47";"1";"5.00";"14; DCC-2701";"O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"16.33";"0.31";"3.34";"7.62";"1";"CHEMBL3857927";"Inhibition of TrkB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856219";"1";"Scientific Literature";"J Med Chem";"2016";"None";""
"CHEMBL4472247";"";"0";"438.54";"0";"4.27";"L785-0018";"CCc1ccc(NC(=O)Nc2nnc(SCc3nc4ccccc4[nH]c3=O)s2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.72";"0.21";"0.43";"4.17";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4450785";"";"0";"444.54";"1";"5.50";"L365-0794";"CCn1c(CCc2ccc(NC(=O)Nc3cc(OC)cc(OC)c3)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.57";"0.19";"-0.80";"6.07";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4591596";"";"0";"400.48";"1";"5.31";"L365-0062";"COc1ccc(C)cc1NC(=O)Nc1ccc(CCc2nc3ccccc3[nH]2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.73";"0.21";"-0.61";"5.95";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4515321";"";"0";"454.54";"0";"3.80";"G755-0355";"COc1cccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.34";"0.21";"0.90";"4.25";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4456764";"";"0";"434.93";"1";"5.66";"L365-1402";"COc1ccc(Cl)cc1NC(=O)Nc1ccc(CCc2nc3ccccc3n2C)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.80";"0.21";"-0.96";"6.89";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4460719";"";"0";"432.87";"0";"3.52";"3";"NC(=O)c1cc(NC(=O)c2cc(-c3cccc(N)n3)ccc2Cl)n(-c2ccccc2)n1";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4309192";"Antagonist activity at prolink-tagged TrkB (unknown origin) expressed in cells assessed as inhibition of BDNF-induced receptor phosphorylation by measuring reduction in EA-tagged SH2 protein recruitment preincubated for 30 mins followed by BDNF addition measured after 2 hrs by PathHunter enzyme complementation assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4308832";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4449648";"";"0";"401.42";"0";"2.93";"10";"CC(C)N1Cc2cc(c(F)cc2F)OCCCNC(=O)c2cnn3ccc1nc23";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"13.21";"0.25";"2.37";"7.39";"0";"CHEMBL4349460";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4472006";"";"0";"368.46";"0";"4.61";"Z15486561";"CCC(C)c1ccc(NC(=O)COC(=O)c2ccc3ncsc3c2)cc1";"IC50";"'='";"10461.4";"nM";"4.98";"";"";"UO_0000065";"13.52";"0.26";"0.37";"7.29";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4518108";"";"0";"442.50";"0";"3.93";"G755-0367";"Cc1cccn2c(=O)cc(CSc3nnc(NC(=O)Nc4ccccc4F)s3)nc12";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.30";"0.23";"1.07";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4533532";"";"0";"462.92";"0";"4.27";"G755-0736";"O=C(Nc1ccc(F)cc1)Nc1nnc(SCc2cc(=O)n3cc(Cl)ccc3n2)s1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.15";"0.21";"0.43";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4450466";"";"0";"442.50";"0";"3.93";"G755-0467";"Cc1ccn2c(=O)cc(CSc3nnc(NC(=O)Nc4ccccc4F)s3)nc2c1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.30";"0.23";"1.07";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4467890";"";"0";"492.51";"0";"4.81";"G755-0459";"Cc1ccn2c(=O)cc(CSc3nnc(NC(=O)Nc4cccc(C(F)(F)F)c4)s3)nc2c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.54";"0.19";"-0.11";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL3982112";"";"0";"446.49";"0";"4.09";"10";"CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3ccc(C4CC4)n3)c2)c2cncc(F)c21";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"18.26";"0.34";"4.06";"8.61";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL3582434";"";"0";"397.46";"1";"5.14";"9";"N#Cc1ccc(-c2cnc3ccc(N4CCCCC4c4cccc(F)c4)nn23)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"18.37";"0.33";"2.16";"12.76";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL4743163";"";"0";"430.50";"0";"4.86";"9f";"CC(C)N(C(=O)Nc1cnn2ccc(N(C)[C@H](C)c3cc(F)ccc3F)nc12)C(C)C";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"20.02";"0.38";"3.76";"13.11";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL23254";"PURVALANOL B";"0";"432.91";"0";"3.93";"Purvalanol B";"CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(=O)O)c(Cl)c2)c2ncn(C(C)C)c2n1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"13.60";"0.27";"1.96";"4.70";"0";"CHEMBL3225463";"Inhibition of TrkB (unknown origin) by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217685";"1";"Scientific Literature";"MedChemComm";"2012";"None";""
"CHEMBL509032";"TAE-684";"0";"614.22";"2";"5.02";"12, NVP-TAE684";"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1";"IC50";"'='";"422000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006350";"Inhibition of TRKB kinase";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156430";"1";"Scientific Literature";"Proc. Natl. Acad. Sci. U.S.A.";"2007";"None";""
"CHEMBL4168305";"";"0";"560.62";"2";"5.27";"5n";"CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"13.20";"0.25";"2.13";"11.25";"0";"CHEMBL4151626";"Inhibition of TrkB (unknown origin) by TR-FRET based LANCE ULTRA kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145679";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL3673472";"";"0";"496.61";"1";"5.53";"BDBM164923";"COc1ccc(COc2ccc(Cn3cnc4cc(C5=CC6(C)CCCN5C6)ccc43)cc2OC)cn1";"IC50";"'='";"889.0";"nM";"6.05";"";"308482";"UO_0000065";"12.18";"0.22";"0.52";"9.82";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678285";"";"0";"483.58";"0";"4.57";"BDBM164943";"COc1cc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(C(C)C)nc1";"IC50";"'='";"0.2";"nM";"9.70";"";"308502";"UO_0000065";"20.06";"0.37";"5.13";"9.16";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678293";"";"0";"498.56";"1";"6.03";"BDBM164951";"COc1ccc(COc2ccc(C(C)n3c(N)nc4cc(-c5ccc(F)cc5)ccc43)cc2OC)cn1";"IC50";"'='";"37.0";"nM";"7.43";"";"308510";"UO_0000065";"14.91";"0.27";"1.40";"8.80";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL103667";"DORAMAPIMOD";"2";"527.67";"2";"5.99";"BIRB-796";"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4602937";"Inhibition of human TRKB";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602604";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL457614";"";"0";"391.84";"0";"4.09";"T1; Type I";"CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)ncc2Cl)n[nH]1";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3997038";"Inhibition of recombinant human TrkB expressed in DHFR deficient CHO cells assessed as inhibition of human brain-derived neurotrophic factor-induced calcium influx by Fluo-4 AM dye based assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3994638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3673489";"";"0";"558.51";"2";"5.70";"BDBM164940";"COc1cc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(C(F)(F)C(F)(F)F)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"308499";"UO_0000065";"16.51";"0.31";"3.52";"9.91";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678284";"";"0";"540.57";"2";"5.66";"BDBM164942";"COc1cc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(SC(F)(F)F)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"308501";"UO_0000065";"17.06";"0.33";"3.56";"9.91";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678298";"";"0";"522.53";"2";"5.63";"BDBM164957";"COc1cc([C@@H](C)n2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"308515";"UO_0000065";"16.31";"0.31";"2.89";"9.16";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678299";"";"0";"508.50";"2";"5.44";"BDBM164961";"COc1cc(C(C)n2cnc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(C(F)(F)F)nc1";"IC50";"'='";"1.0";"nM";"9.00";"";"308516";"UO_0000065";"17.70";"0.33";"3.56";"11.27";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678304";"";"0";"470.53";"0";"4.43";"BDBM164967";"COc1ccc(C(C)Oc2ccc(Cn3cnc4cc(-c5ccnn5C)cnc43)cc2OC)cn1";"IC50";"'='";"219.0";"nM";"6.66";"";"308521";"UO_0000065";"14.15";"0.26";"2.23";"7.47";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4797186";"";"0";"365.41";"1";"5.56";"7c";"Fc1cc(F)cc(Sc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"22.77";"0.44";"2.76";"20.01";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4444267";"";"0";"487.56";"0";"3.95";"Z25290811";"CC(C)(C)c1cc(NC(=O)COC(=O)c2ccc3c(c2)NC2CCCN2C3=O)n(-c2ccccc2)n1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.64";"0.18";"0.75";"4.45";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4454504";"";"0";"452.57";"0";"4.41";"G755-0339";"Cc1cc(C)cc(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)c1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.05";"0.22";"0.59";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4535153";"";"0";"418.93";"1";"6.14";"L365-0744";"CCn1c(CCc2ccc(NC(=O)Nc3ccccc3Cl)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.22";"0.21";"-1.44";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4472183";"";"0";"454.54";"0";"3.80";"G755-0555";"COc1cccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cc(C)ccc4n3)s2)c1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.00";"0.22";"1.20";"4.52";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4518910";"";"0";"398.51";"1";"5.79";"L365-0773";"CCn1c(CCc2ccc(NC(=O)Nc3cccc(C)c3)cc2)nc2ccccc21";"IC50";"'='";"2843.4";"nM";"5.55";"";"";"UO_0000065";"13.92";"0.25";"-0.24";"9.41";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4561854";"";"0";"474.56";"1";"5.51";"L365-0779";"CCn1c(CCc2ccc(NC(=O)Nc3cc(OC)c(OC)c(OC)c3)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.90";"0.18";"-0.81";"5.42";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4592731";"";"0";"398.51";"1";"5.62";"L365-1399";"Cc1cc(C)cc(NC(=O)Nc2ccc(CCc3nc4ccccc4n3C)cc2)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.79";"0.21";"-0.92";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4448594";"";"0";"422.89";"1";"5.80";"L365-1408";"Cn1c(CCc2ccc(NC(=O)Nc3ccc(F)c(Cl)c3)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.11";"0.21";"-1.10";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4524989";"";"0";"454.54";"0";"3.80";"G755-0447";"COc1ccccc1NC(=O)Nc1nnc(SCc2cc(=O)n3ccc(C)cc3n2)s1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.34";"0.21";"0.90";"4.25";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4576971";"";"0";"398.51";"1";"5.62";"L365-1398";"Cc1ccc(C)c(NC(=O)Nc2ccc(CCc3nc4ccccc4n3C)cc2)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.79";"0.21";"-0.92";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4634634";"";"0";"365.44";"0";"1.44";"29";"C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4603560";"Inhibition of recombinant human His-tagged NTRK2 cytoplasmic domain (526 to 838 residues) expressed in baculovirus expression system using tyrosine-01 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";""
"CHEMBL4438018";"";"0";"472.98";"0";"4.75";"G755-0345";"Cc1ccc(Cl)cc1NC(=O)Nc1nnc(SCc2cc(=O)n3cccc(C)c3n2)s1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.57";"0.22";"0.25";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4482862";"";"0";"464.45";"0";"4.76";"7a";"Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)CN(c3cncnc3)C4)cc(C(F)(F)F)c2)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4568103";"";"0";"478.48";"0";"4.76";"7b";"Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)CN(Cc3cncnc3)C4)cc(C(F)(F)F)c2)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3673445";"";"0";"458.56";"0";"4.54";"BDBM164894";"COc1ccc(COc2ccc(Cn3cnc4cc(C5CCNCC5)ccc43)cc2OC)cn1";"IC50";"'='";"3460.0";"nM";"5.46";"";"308453";"UO_0000065";"11.91";"0.22";"0.92";"7.75";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4448181";"";"0";"470.61";"0";"4.51";"G755-0364";"CSc1cccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)c1";"IC50";"'='";"6706.0";"nM";"5.17";"";"";"UO_0000065";"10.99";"0.23";"0.66";"5.11";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4461469";"";"0";"418.93";"1";"6.14";"L365-0743";"CCn1c(CCc2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)nc2ccccc21";"IC50";"'='";"1196.8";"nM";"5.92";"";"";"UO_0000065";"14.14";"0.27";"-0.22";"10.05";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4449690";"";"0";"464.95";"1";"5.67";"L365-1410";"COc1cc(OC)c(NC(=O)Nc2ccc(CCc3nc4ccccc4n3C)cc2)cc1Cl";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.11";"0.19";"-0.97";"6.07";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4564020";"";"0";"444.93";"0";"4.36";"L150-0693";"O=C(Nc1cccc(Cl)c1)Nc1nnc(SCc2nc3ccccc3[nH]c2=O)s1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.56";"0.22";"0.34";"4.17";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4458775";"";"0";"472.98";"0";"4.75";"G755-0435";"Cc1ccn2c(=O)cc(CSc3nnc(NC(=O)Nc4ccc(C)c(Cl)c4)s3)nc2c1";"IC50";"'='";"771.0";"nM";"6.11";"";"";"UO_0000065";"12.92";"0.27";"1.36";"6.04";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4521004";"";"0";"430.51";"1";"5.02";"L365-1440";"COc1ccc(NC(=O)Nc2ccc(CCc3nc4ccccc4n3C)cc2)c(OC)c1";"IC50";"'='";"3886.6";"nM";"5.41";"";"";"UO_0000065";"12.57";"0.23";"0.39";"6.99";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4592814";"";"0";"430.58";"1";"6.21";"L365-0809";"CCn1c(CCc2ccc(NC(=O)Nc3cccc(SC)c3)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.91";"0.21";"-1.51";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4536149";"";"0";"428.54";"1";"5.80";"L365-0799";"CCn1c(CCc2ccc(NC(=O)Nc3cc(C)ccc3OC)cc2)nc2ccccc21";"IC50";"'='";"778.0";"nM";"6.11";"";"";"UO_0000065";"14.26";"0.26";"0.31";"8.96";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4748010";"";"0";"450.45";"0";"3.68";"2";"CC(C)n1cc(C(=O)c2ccnc(NC(=O)Cc3ccc(F)cc3F)c2)c2c(N)ncnc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL4473502";"";"0";"546.60";"1";"4.71";"9g";"CCc1c(C#Cc2cnc3cnccn23)cccc1C(=O)Nc1cc(CN2CCN(C)CC2)cc(C(F)(F)F)c1";"IC50";"'='";"315.13";"nM";"6.50";"";"";"UO_0000065";"11.89";"0.22";"1.79";"9.89";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4579323";"";"0";"583.74";"2";"5.25";"9n";"CCc1cc(CN2CCN(C)CC2)cc(NC(=O)c2cccc(C#Cc3cnc4cnc(-c5ccc(N)cc5)cn34)c2C)c1";"IC50";"'='";"9.3";"nM";"8.03";"";"";"UO_0000065";"13.76";"0.25";"2.78";"8.75";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4525857";"";"0";"380.35";"0";"4.11";"Z15486577";"O=C(COC(=O)c1ccc2ncsc2c1)Nc1ccc(C(F)(F)F)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"12.35";"0.25";"0.59";"6.88";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4469499";"";"0";"355.35";"0";"2.38";"Z18544949";"COc1ccc(NC(=O)COC(=O)c2n[nH]c3ccccc23)cc1OC";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"13.22";"0.25";"2.32";"4.58";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4555143";"";"0";"433.54";"0";"3.88";"1a; Z25096805";"CC(C)(C)c1cc(NC(=O)CSc2nnnn2-c2ccccc2)n(-c2ccccc2)n1";"IC50";"'='";"40.1";"nM";"7.40";"";"";"UO_0000065";"17.06";"0.33";"3.52";"8.17";"0";"CHEMBL4400008";"Inhibition of inactive recombinant human His-tagged TrkB expressed in baculovirus expression system preincubated for 20 mins followed by ATP/SRCtide substarte addition further incubated for 2 hrs by caliper microfluidic mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";""
"CHEMBL4755144";"";"0";"452.92";"1";"5.85";"6; F690-0215";"COc1ccc(Cl)cc1NC(=O)Nc1ccc2nc(NC(=O)c3ccccc3)sc2c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4716029";"Inhibition of human TRKB by FLIPR assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715685";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";""
"CHEMBL4799340";"";"0";"348.36";"1";"5.15";"7e";"Fc1cc(F)cc(Nc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"30.7";"nM";"7.51";"";"";"UO_0000065";"21.57";"0.39";"2.36";"14.02";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4796985";"";"0";"376.37";"0";"4.66";"7i";"O=C(Nc1cc(F)cc(F)c1)c1ccc2[nH]nc(/C=C/c3ccccn3)c2c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4796220";"";"0";"358.42";"1";"5.19";"7w";"Cc1cc(F)cc(CNc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"50.1";"nM";"7.30";"";"";"UO_0000065";"20.37";"0.37";"2.11";"13.62";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4861572";"";"0";"485.47";"1";"5.07";"1";"COCc1ccc(OC(F)(F)F)c(CNC(=O)Nc2c(-c3ccccc3)nc3c(C)nccn23)c1";"IC50";"'='";"289.0";"nM";"6.54";"";"";"UO_0000065";"13.47";"0.26";"1.47";"7.28";"0";"CHEMBL4842083";"Inhibition of human TRKB expressed in human U2OS cells assessed as inhibition of substrate hydrolysis pretreated for 30 mins followed by BDNF agonist addition and measured after 2 hrs by chemiluminescence based pathHunter assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840366";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.5 hr"
"CHEMBL4464426";"";"0";"560.62";"2";"5.10";"9h";"CCCc1c(C#Cc2cnc3cnccn23)cccc1C(=O)Nc1cc(CN2CCN(C)CC2)cc(C(F)(F)F)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4464655";"";"0";"560.62";"2";"5.27";"9i";"CC(C)c1c(C#Cc2cnc3cnccn23)cccc1C(=O)Nc1cc(CN2CCN(C)CC2)cc(C(F)(F)F)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4800240";"";"0";"457.38";"0";"1.68";"2; Z106765954";"NC(=O)c1ccc(-c2nnn(CC(=O)Nc3cc(C(F)(F)F)ccc3-n3cncn3)n2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4716029";"Inhibition of human TRKB by FLIPR assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715685";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";""
"CHEMBL4763430";"";"0";"416.43";"0";"2.80";"9a";"C[C@H](c1cc(F)ccc1F)N(C)c1ccn2ncc(NC(=O)N3CC[C@H](O)C3)c2n1";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"20.14";"0.38";"5.59";"9.75";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4078893";"";"0";"427.81";"0";"4.43";"7";"FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12";"IC50";"'='";"8340.0";"nM";"5.08";"";"";"UO_0000065";"11.87";"0.24";"0.65";"6.73";"0";"CHEMBL4007753";"Inhibition of TrkB (unknown origin) after 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007384";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL4069365";"";"0";"421.38";"0";"4.14";"13";"CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21";"IC50";"'='";"379.0";"nM";"6.42";"";"";"UO_0000065";"15.24";"0.29";"2.28";"6.34";"0";"CHEMBL4007753";"Inhibition of TrkB (unknown origin) after 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007384";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL3918580";"";"0";"502.57";"2";"5.32";"6";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"13.93";"0.25";"1.68";"6.14";"0";"CHEMBL4429384";"Inhibition of partial length human TRKB expressed in mammalian system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";""
"CHEMBL4211921";"";"0";"489.45";"0";"2.70";"16b";"Cn1cc(-c2ccc(O[C@@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C3)c(C(N)=O)n2)cn1";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"17.51";"0.33";"5.87";"7.61";"0";"CHEMBL4195800";"Antagonist activity at prolink-tagged TrkB in human U2OS cells assessed as inhibition of BDNF-induced receptor phosphorylation by measuring reduction in EA-tagged SH2 protein recruitment preincubated for 30 mins followed by BDNF stimulation measured after 2 hrs by PathHunter enzyme complementation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190406";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4455239";"";"0";"435.33";"1";"5.75";"L365-0031";"O=C(Nc1ccc(CCc2nc3ccccc3[nH]2)cc1)Nc1cccc(Br)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.79";"0.23";"-1.05";"6.73";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4446114";"";"0";"442.50";"0";"3.93";"G755-0567";"Cc1ccc2nc(CSc3nnc(NC(=O)Nc4ccccc4F)s3)cc(=O)n2c1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.30";"0.23";"1.07";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4451361";"";"0";"452.57";"0";"4.41";"G755-0534";"Cc1ccc2nc(CSc3nnc(NC(=O)Nc4cccc(C)c4C)s3)cc(=O)n2c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.38";"0.21";"0.29";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4470164";"";"0";"476.58";"1";"6.85";"L365-3541";"CCOc1ccccc1NC(=O)Nc1ccc(CCc2nc3ccccc3n2-c2ccccc2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.86";"0.18";"-2.15";"6.89";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4472914";"";"0";"478.48";"0";"4.82";"7d";"Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@@H](Nc3cncnc3)C4)cc(C(F)(F)F)c2)cn1";"IC50";"'='";"343.9";"nM";"6.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4794404";"";"0";"473.61";"0";"3.75";"34";"Cc1nc(NC(=O)CN2CCN(C)CC2)sc1-c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1";"IC50";"'='";"0.71";"nM";"9.15";"";"";"UO_0000065";"19.32";"0.37";"5.40";"10.16";"0";"CHEMBL4774749";"Inhibition of human TRKB by Z-LYTE or ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765452";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";""
"CHEMBL457614";"";"0";"391.84";"0";"4.09";"T1; AZ-23";"CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)ncc2Cl)n[nH]1";"IC50";"'='";"0.93";"nM";"9.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343624";"Inhibition of wild type human N-terminal GST-fusion tagged TRKB kinase domain (456 to 822 residues) expressed in baculovirus expression system by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342423";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";""
"CHEMBL3582442";"";"0";"458.54";"0";"4.23";"17";"OC1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"18.31";"0.34";"4.17";"12.03";"0";"CHEMBL3582855";"Inhibition of Tel-fused TRKB (unknown origin) overexpressed in mouse BA/F3 cells assessed as inhibition of cell proliferation after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3580662";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2015";"CHEMBL3307634";""
"CHEMBL3673478";"";"0";"508.50";"2";"5.07";"BDBM164929";"COc1cc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"308488";"UO_0000065";"18.73";"0.35";"4.45";"10.24";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673487";"";"0";"468.52";"0";"4.12";"BDBM164938";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cccnc5)cnc43)cc2OC)cn1";"IC50";"'='";"2.0";"nM";"8.70";"";"308497";"UO_0000065";"18.57";"0.34";"4.58";"7.89";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4216371";"";"0";"488.41";"0";"2.78";"20";"CCNC(=O)c1cnc(N)c(O[C@H]2CN(C(=O)Cc3ccc(OC(F)(F)F)cc3)CC2(F)F)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4195800";"Antagonist activity at prolink-tagged TrkB in human U2OS cells assessed as inhibition of BDNF-induced receptor phosphorylation by measuring reduction in EA-tagged SH2 protein recruitment preincubated for 30 mins followed by BDNF stimulation measured after 2 hrs by PathHunter enzyme complementation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190406";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL3666254";"";"0";"448.91";"0";"4.06";"12";"CC(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cc3)c2)c2cnc(N)nc21";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.38";"0.37";"4.64";"7.51";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL4786112";"";"0";"362.38";"1";"5.02";"7n";"Fc1cc(F)cc(NCc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"23.33";"0.43";"3.44";"15.78";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4577285";"";"0";"454.54";"0";"3.80";"G755-0347";"COc1ccccc1NC(=O)Nc1nnc(SCc2cc(=O)n3cccc(C)c3n2)s1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.34";"0.21";"0.90";"4.25";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL1822792";"MK-2461";"2";"495.56";"0";"2.15";"81, MK-2461";"CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"14.56";"0.28";"5.06";"6.24";"0";"CHEMBL1804198";"Inhibition of human TrkB";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1800066";"1";"Scientific Literature";"J. Med. Chem.";"2011";"None";""
"CHEMBL4776591";"";"0";"362.38";"1";"5.17";"7f";"CN(c1cc(F)cc(F)c1)c1ccc2[nH]nc(/C=C/c3ccccn3)c2c1";"IC50";"'='";"23.6";"nM";"7.63";"";"";"UO_0000065";"21.05";"0.39";"2.46";"17.02";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4777347";"";"0";"376.41";"1";"5.04";"7p";"CN(Cc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1";"IC50";"'='";"42.5";"nM";"7.37";"";"";"UO_0000065";"19.58";"0.36";"2.33";"16.45";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4792981";"";"0";"376.41";"1";"5.58";"7mb";"C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"22.68";"0.42";"2.96";"15.93";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4207042";"";"0";"474.39";"0";"2.39";"19";"CNC(=O)c1cnc(N)c(O[C@H]2CN(C(=O)Cc3ccc(OC(F)(F)F)cc3)CC2(F)F)c1";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"17.30";"0.34";"5.82";"7.69";"0";"CHEMBL4195800";"Antagonist activity at prolink-tagged TrkB in human U2OS cells assessed as inhibition of BDNF-induced receptor phosphorylation by measuring reduction in EA-tagged SH2 protein recruitment preincubated for 30 mins followed by BDNF stimulation measured after 2 hrs by PathHunter enzyme complementation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190406";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL3673443";"";"0";"525.61";"1";"4.12";"BDBM164892";"COc1ccc(COc2ccc(Cn3cnc4cc(-n5cc(C6CCCNC6)nn5)ccc43)cc2OC)cn1";"IC50";"'='";"86.0";"nM";"7.07";"";"308451";"UO_0000065";"13.44";"0.25";"2.95";"6.99";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673479";"";"0";"481.56";"0";"4.32";"BDBM164930";"COc1cc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(C2CC2)nc1";"IC50";"'='";"0.2";"nM";"9.70";"";"308489";"UO_0000065";"20.14";"0.37";"5.38";"9.16";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4454926";"";"0";"425.51";"0";"3.32";"Z53801161";"NC(=O)c1c(NC(=O)COC(=O)CCCc2c[nH]c3ccccc23)sc2c1CCC2";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.04";"0.21";"1.38";"4.11";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4476611";"";"0";"447.32";"0";"4.67";"Z18518113";"CC(C)(C)c1cc(NC(=O)COC(=O)c2cnc(Cl)c(Cl)c2)n(-c2ccccc2)n1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.50";"0.21";"0.03";"5.46";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4469681";"";"0";"358.35";"0";"2.03";"8";"NC(=O)c1c(N)nn2cc(N3CCC[C@@H]3c3cc(F)ccc3F)cnc12";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4349456";"Inhibition of N- terminal GST-tagged human TRKB cytoplasmic domain (456 to 822 end residues) expressed in baculovirus expression system using TK peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL2006765";"";"0";"392.39";"0";"3.82";"5";"CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1";"IC50";"'='";"126.0";"nM";"6.90";"";"";"UO_0000065";"17.58";"0.34";"3.08";"7.28";"0";"CHEMBL4007753";"Inhibition of TrkB (unknown origin) after 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007384";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL4440941";"";"0";"434.50";"0";"3.92";"Z18262421";"CC(=O)Nc1ccc(C(=O)OCC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.81";"0.20";"0.78";"4.59";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4453766";"";"0";"362.41";"0";"4.25";"Z15486558";"O=C(COC(=O)c1ccc2ncsc2c1)Nc1ccc2ccccc2c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"12.97";"0.25";"0.45";"6.88";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL1710419";"";"0";"396.35";"0";"3.99";"Z15486422";"O=C(COC(=O)c1ccc2ncsc2c1)Nc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.86";"0.24";"0.71";"6.06";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4470262";"";"0";"520.56";"2";"5.63";"7h";"CCCN(c1cncnc1)[C@@H]1Cc2ccc(C(=O)Nc3cc(-n4cnc(C)c4)cc(C(F)(F)F)c3)cc2C1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4585974";"";"0";"438.54";"0";"4.14";"7i";"Cc1cc(NC(=O)c2ccc3c(c2)C[C@H](N(C)c2cncnc2)C3)cc(-n2cnc(C)c2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4868797";"";"0";"500.63";"2";"5.05";"4c";"Cn1cc(-c2cc3ncnc(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)nn5C)cc4)c3s2)cn1";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"14.24";"0.27";"2.08";"6.95";"0";"CHEMBL4815835";"Inhibition of recombinant His-tagged human TRKB expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 1 hr followed by substrate addition in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4813963";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.0 hr"
"CHEMBL4782515";"";"0";"363.37";"0";"4.99";"7k";"Fc1cc(F)cc(COc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"24.55";"0.45";"3.93";"17.56";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4785469";"";"0";"362.38";"1";"5.02";"7m";"Fc1cc(F)cc(CNc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"8.3";"nM";"8.08";"";"";"UO_0000065";"22.30";"0.41";"3.06";"15.08";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4783132";"";"0";"369.40";"0";"4.75";"7z";"N#Cc1cc(F)cc(CNc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"17.7";"nM";"7.75";"";"";"UO_0000065";"20.99";"0.38";"3.00";"10.02";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4636995";"";"0";"466.57";"0";"3.59";"4";"COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC";"IC50";"'='";"770.0";"nM";"6.11";"";"";"UO_0000065";"13.10";"0.25";"2.52";"6.11";"0";"CHEMBL4605821";"Inhibition of TRKB (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602715";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307634";""
"CHEMBL4794903";"";"0";"439.48";"0";"3.27";"6";"CC(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(C#N)cc3)c2)c2c(N)ncnc21";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"18.42";"0.34";"4.83";"5.80";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL3942935";"";"0";"428.50";"0";"3.96";"9";"CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3ccc(C4CC4)n3)c2)c2cnccc21";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"19.37";"0.35";"4.34";"8.77";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL4542472";"";"0";"428.54";"1";"5.88";"L365-0767";"CCOc1ccccc1NC(=O)Nc1ccc(CCc2nc3ccccc3n2CC)cc1";"IC50";"'='";"2594.4";"nM";"5.59";"";"";"UO_0000065";"13.03";"0.24";"-0.29";"8.19";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4520451";"";"0";"449.35";"1";"5.77";"L365-1416";"Cn1c(CCc2ccc(NC(=O)Nc3cccc(Br)c3)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.46";"0.22";"-1.07";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4856292";"";"0";"428.44";"0";"2.95";"Larotrectinib";"O=C(Nc1cnn2ccc(N3CCC[C@H]3c3cc(F)ccc3F)nc12)N1CC[C@@H](O)C1";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"19.44";"0.37";"5.38";"9.68";"0";"CHEMBL4840465";"Inhibition of N-terminal GST-tagged human TRKB (456 to 822 residues) expressed in baculovirus infected Sf21 cells using TK as substrate in presence of ATP measured after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840303";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr"
"CHEMBL3889654";"LAROTRECTINIB";"4";"428.44";"0";"2.95";"Larotrectinib";"O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"20.25";"0.38";"5.73";"10.09";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4798255";"";"0";"397.46";"0";"2.63";"3a25";"CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2";"IC50";"'='";"13.45";"nM";"7.87";"";"";"UO_0000065";"19.80";"0.38";"5.24";"8.59";"0";"CHEMBL4765714";"Inhibition of TrkB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765228";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";""
"CHEMBL4467462";"";"0";"532.57";"1";"4.46";"9c";"Cc1c(C#Cc2cnc3cnccn23)cccc1C(=O)Nc1cc(CN2CCN(C)CC2)cc(C(F)(F)F)c1";"IC50";"'='";"38.35";"nM";"7.42";"";"";"UO_0000065";"13.93";"0.26";"2.96";"11.28";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL388978";"STAUROSPORINE";"0";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"0.96";"nM";"9.02";"";"";"UO_0000065";"19.33";"0.35";"4.67";"12.98";"0";"CHEMBL3225463";"Inhibition of TrkB (unknown origin) by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217685";"1";"Scientific Literature";"MedChemComm";"2012";"None";""
"CHEMBL2172308";"";"0";"577.75";"2";"5.09";"5-3; TSR-011";"CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1";"IC50";"'<'";"3.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4330192";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330054";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4557960";"";"0";"438.45";"1";"6.02";"L365-1442";"Cn1c(CCc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.72";"0.20";"-1.32";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4575376";"";"0";"404.90";"1";"5.66";"L365-1389";"Cn1c(CCc2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.61";"0.22";"-0.96";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4449741";"";"0";"468.56";"0";"4.19";"G755-0348";"CCOc1ccccc1NC(=O)Nc1nnc(SCc2cc(=O)n3cccc(C)c3n2)s1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.03";"0.20";"0.51";"4.25";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4461026";"";"0";"526.43";"1";"4.99";"20";"CN(C)CCCc1cc(C(=O)c2cccc(NC(=O)Nc3ccc(Cl)cc3Cl)c2)c2c(N)ncnn12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"17.10";"0.34";"4.01";"7.65";"0";"CHEMBL4349460";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL1983268";"ENTRECTINIB";"4";"560.65";"2";"5.03";"84";"CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4349460";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4794286";"";"0";"412.39";"1";"5.90";"7y";"Fc1cc(CNc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)cc(C(F)(F)F)c1";"IC50";"'='";"245.2";"nM";"6.61";"";"";"UO_0000065";"16.03";"0.30";"0.71";"12.33";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4740028";"";"0";"434.50";"0";"2.19";"4; Z51835631";"O=C(Nc1ccc(N2CCOCC2)cc1N1CCOCC1)c1cnn(-c2ccccc2)n1";"IC50";"'='";"15900.0";"nM";"4.80";"";"";"UO_0000065";"11.04";"0.20";"2.61";"5.66";"0";"CHEMBL4716029";"Inhibition of human TRKB by FLIPR assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715685";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";""
"CHEMBL3629013";"";"0";"392.51";"0";"3.59";"11";"N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1";"IC50";"'='";"1190000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3631845";"Inhibition of TrkB (unknown origin) by FRET method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627690";"1";"Scientific Literature";"J. Med. Chem.";"2015";"None";""
"CHEMBL4447685";"";"0";"445.48";"0";"2.94";"2a; Z25180415";"CC(C)(C)c1cc(NC(=O)COC(=O)c2ccc(-n3cnnn3)cc2)n(-c2ccccc2)n1";"IC50";"'='";"47.1";"nM";"7.33";"";"";"UO_0000065";"16.45";"0.30";"4.39";"6.27";"0";"CHEMBL4400008";"Inhibition of inactive recombinant human His-tagged TrkB expressed in baculovirus expression system preincubated for 20 mins followed by ATP/SRCtide substarte addition further incubated for 2 hrs by caliper microfluidic mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";""
"CHEMBL322153";"";"0";"411.48";"0";"2.93";"2a25";"COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C";"IC50";"'='";"141.83";"nM";"6.85";"";"";"UO_0000065";"16.64";"0.32";"3.92";"8.49";"0";"CHEMBL4765712";"Inhibition of GAL4 fused TrkB (unknown origin) expressed in MG87 cells transfected with pFA2-Elk plasmid and pFR-luciferase plasmid measured for 18 hrs by luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MG87";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765228";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"TIME = 18.0 hr"
"CHEMBL106226";"";"0";"369.40";"0";"2.32";"2a23";"COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1";"IC50";"'='";"8.53";"nM";"8.07";"";"";"UO_0000065";"21.84";"0.42";"5.75";"7.06";"0";"CHEMBL4765714";"Inhibition of TrkB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765228";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";""
"CHEMBL4578725";"";"0";"462.92";"0";"4.50";"L785-0030";"O=C(Nc1ccc(F)c(Cl)c1)Nc1nnc(SCc2nc3ccccc3[nH]c2=O)s1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.80";"0.23";"0.50";"4.44";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4584518";"";"0";"456.53";"0";"4.24";"G755-0454";"Cc1ccn2c(=O)cc(CSc3nnc(NC(=O)Nc4ccc(C)c(F)c4)s3)nc2c1";"IC50";"'='";"4615.5";"nM";"5.34";"";"";"UO_0000065";"11.69";"0.24";"1.10";"5.27";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4543982";"";"0";"414.51";"1";"5.40";"L365-1414";"CCOc1ccccc1NC(=O)Nc1ccc(CCc2nc3ccccc3n2C)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.34";"0.21";"-0.70";"6.89";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4443356";"";"0";"402.47";"1";"5.62";"L365-0798";"CCn1c(CCc2ccc(NC(=O)Nc3ccccc3F)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.68";"0.21";"-0.92";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4587651";"";"0";"518.54";"1";"4.15";"9d";"CN1CCN(Cc2cc(NC(=O)c3cccc(C#Cc4cnc5cnccn45)c3)cc(C(F)(F)F)c2)CC1";"IC50";"'='";"43.92";"nM";"7.36";"";"";"UO_0000065";"14.19";"0.26";"3.21";"11.19";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4780959";"";"0";"424.41";"0";"4.53";"8b";"C[C@@H](Nc1ccn2ncc(NC(=O)Nc3ccc(O)cc3)c2n1)c1cc(F)ccc1F";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"16.61";"0.31";"2.52";"6.81";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4281823";"";"0";"481.48";"0";"4.73";"22b";"CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"16.82";"0.32";"3.37";"9.39";"0";"CHEMBL4261432";"Inhibition of recombinant human TrkB (455 to end residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257593";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4536799";"";"0";"410.48";"0";"3.71";"L785-0024";"O=C(Nc1ccccc1)Nc1nnc(SCc2nc3ccccc3[nH]c2=O)s1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.45";"0.23";"0.99";"4.17";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4531238";"";"0";"484.56";"0";"3.81";"G755-0341";"COc1ccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)cc1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.32";"0.21";"1.19";"4.18";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4788009";"";"0";"426.40";"0";"4.00";"1; D458-0459";"Cc1nc2nc(-c3cccnc3)nn2c(C)c1CC(=O)Nc1cccc(C(F)(F)F)c1";"IC50";"'='";"7700.0";"nM";"5.11";"";"";"UO_0000065";"11.99";"0.23";"1.11";"6.01";"0";"CHEMBL4716029";"Inhibition of human TRKB by FLIPR assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715685";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";""
"CHEMBL4759162";"";"0";"431.49";"0";"3.23";"9h";"C[C@H](c1cc(F)ccc1F)N(C)c1ccn2ncc(NC(=O)N(C)CCN(C)C)c2n1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"18.20";"0.35";"4.62";"11.38";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4787769";"";"0";"418.45";"0";"3.10";"9d";"CCC(CO)NC(=O)Nc1cnn2ccc(N(C)[C@H](C)c3cc(F)ccc3F)nc12";"IC50";"'='";"146.0";"nM";"6.84";"";"";"UO_0000065";"16.34";"0.31";"3.74";"7.21";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4778061";"";"0";"417.46";"0";"3.21";"8h";"C[C@@H](Nc1ccn2ncc(NC(=O)N(C)CCN(C)C)c2n1)c1cc(F)ccc1F";"IC50";"'='";"221.0";"nM";"6.66";"";"";"UO_0000065";"15.94";"0.30";"3.45";"8.55";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4795791";"";"0";"438.44";"0";"4.55";"9b";"C[C@H](c1cc(F)ccc1F)N(C)c1ccn2ncc(NC(=O)Nc3ccc(O)cc3)c2n1";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"19.41";"0.36";"3.96";"8.98";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4558430";"";"0";"478.48";"0";"4.82";"7c";"Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](Nc3cncnc3)C4)cc(C(F)(F)F)c2)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4555143";"";"0";"433.54";"0";"3.88";"1a; Z25096805";"CC(C)(C)c1cc(NC(=O)CSc2nnnn2-c2ccccc2)n(-c2ccccc2)n1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.84";"0.21";"0.82";"5.19";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4579301";"";"0";"463.57";"0";"3.88";"Z19622922";"COc1ccc(-n2nnnc2SCC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.14";"0.19";"0.82";"4.71";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4475899";"";"0";"402.45";"0";"3.84";"Z18372581";"CC(C)(C)c1cc(NC(=O)COC(=O)c2ccc(C#N)cc2)n(-c2ccccc2)n1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.68";"0.21";"0.86";"4.84";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4534509";"";"0";"434.90";"0";"3.13";"Z18429103";"NC(=O)c1c(NC(=O)COC(=O)CCC(=O)c2ccc(Cl)cc2)sc2c1CCC2";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.80";"0.22";"1.57";"4.07";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4541139";"";"0";"452.56";"0";"4.39";"7j";"CCc1cc(NC(=O)c2ccc3c(c2)C[C@H](N(C)c2cncnc2)C3)cc(-n2cnc(C)c2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL1980995";"";"0";"466.54";"0";"4.35";"BDBM130909";"CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"1.182";"nM";"8.93";"";"263059";"UO_0000065";"19.14";"0.35";"4.58";"12.85";"0";"CHEMBL3707732";"In Vitro Kinase Activity Assay: Compounds to be tested were dissolved in 100% DMSO in a range of concentrations from 10-8 to 10-3 M including negative control (DMSO), then diluted with Kinase Buffer (50 mM HEPES, pH 7.5, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, and 2 mM DTT, added fresh) to 4x the final concentration. The final curve included 11 concentrations (10-11 to 10-5 M) plus negative control DMSO tested in triplicate.Kinase and ATP concentrations necessary for optimal activity were determined in separate experiments. (Table 2). Briefly, increasing concentrations of kinase were incubated in a fixed concentration of ATP (200 uM) in Kinase Buffer to determine maximal activity at various time points (30-120 min). The concentration of kinase that resulted in maximal activity with the shortest incubation time was then incubated in Kinase Buffer with increasing concentrations of ATP.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639188";"37";"BindingDB Database";"";"2014";"None";""
"CHEMBL3673436";"";"0";"469.55";"0";"4.66";"BDBM164885";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cnn(C)c5)ccc43)cc2OC)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"308444";"UO_0000065";"19.81";"0.36";"4.64";"10.41";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673448";"";"0";"499.62";"0";"4.27";"BDBM164897";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CC6(CCNCC6)C5)ccc43)cc2OC)cn1";"IC50";"'='";"120.0";"nM";"6.92";"";"308456";"UO_0000065";"13.85";"0.26";"2.65";"9.39";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673454";"";"0";"474.57";"0";"3.22";"BDBM164903";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CCN(C)CC5)cnc43)cc2OC)cn1";"IC50";"'='";"179.0";"nM";"6.75";"";"308479";"UO_0000065";"14.22";"0.26";"3.53";"8.68";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678294";"";"0";"521.51";"2";"7.45";"BDBM164952";"COc1cc(C(C)n2cnc3cc(-c4ccc(F)cc4)ccc32)ccc1OCc1ccc(C(F)(F)F)nc1";"IC50";"'='";"427.0";"nM";"6.37";"";"308511";"UO_0000065";"12.21";"0.23";"-1.08";"12.95";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678300";"";"0";"523.52";"2";"5.02";"BDBM164962";"COc1cc(C(C)n2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(C(F)(F)F)nc1";"IC50";"'='";"0.6";"nM";"9.22";"";"308517";"UO_0000065";"17.62";"0.33";"4.20";"8.71";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678306";"";"0";"485.52";"1";"5.23";"BDBM164969";"COc1ccc(C(C)Oc2ccc(Cn3cnc4cc(-c5ccnc(F)c5)cnc43)cc2OC)cn1";"IC50";"'='";"68.0";"nM";"7.17";"";"308523";"UO_0000065";"14.76";"0.27";"1.94";"8.51";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4469795";"";"0";"608.67";"2";"6.12";"9k";"Cc1c(C#Cc2cnc3cnc(-c4ccccc4)cn23)cccc1C(=O)Nc1cc(CN2CCN(C)CC2)cc(C(F)(F)F)c1";"IC50";"'='";"22.73";"nM";"7.64";"";"";"UO_0000065";"12.56";"0.23";"1.52";"11.62";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4447582";"";"0";"597.77";"2";"5.81";"9o";"Cc1c(C#Cc2cnc3cnc(-c4ccc(N)cc4)cn23)cccc1C(=O)Nc1cc(CN2CCN(C)CC2)cc(C(C)C)c1";"IC50";"'='";"10.47";"nM";"7.98";"";"";"UO_0000065";"13.35";"0.24";"2.17";"8.69";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4454061";"";"0";"609.66";"2";"5.52";"9l";"Cc1c(C#Cc2cnc3cnc(-c4ccncc4)cn23)cccc1C(=O)Nc1cc(CN2CCN(C)CC2)cc(C(F)(F)F)c1";"IC50";"'='";"43.47";"nM";"7.36";"";"";"UO_0000065";"12.08";"0.22";"1.84";"9.36";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4470140";"";"0";"452.57";"0";"4.41";"G755-0538";"Cc1ccc(C)c(NC(=O)Nc2nnc(SCc3cc(=O)n4cc(C)ccc4n3)s2)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.38";"0.21";"0.29";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4446374";"";"0";"430.51";"1";"5.02";"L365-1441";"COc1cc(NC(=O)Nc2ccc(CCc3nc4ccccc4n3C)cc2)cc(OC)c1";"IC50";"'='";"3575.6";"nM";"5.45";"";"";"UO_0000065";"12.65";"0.23";"0.43";"7.04";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4443873";"";"0";"496.57";"0";"3.97";"G755-0344";"CCOC(=O)c1ccccc1NC(=O)Nc1nnc(SCc2cc(=O)n3cccc(C)c3n2)s1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.46";"0.19";"0.73";"3.68";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4527557";"";"0";"472.98";"0";"4.75";"G755-0340";"Cc1ccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cccc(C)c4n3)s2)c(Cl)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.93";"0.21";"-0.05";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4439853";"";"0";"484.56";"0";"3.81";"G755-0441";"COc1ccc(NC(=O)Nc2nnc(SCc3cc(=O)n4ccc(C)cc4n3)s2)cc1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.32";"0.21";"1.19";"4.18";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4461048";"";"0";"623.68";"2";"5.71";"9j";"Cc1c(C#Cc2cnc3cnc(-c4ccc(N)cc4)cn23)cccc1C(=O)Nc1cc(CN2CCN(C)CC2)cc(C(F)(F)F)c1";"IC50";"'='";"13.11";"nM";"7.88";"";"";"UO_0000065";"12.64";"0.23";"2.17";"8.59";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4858720";"";"0";"310.36";"0";"2.33";"2";"Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CO)C1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"18.97";"0.35";"3.56";"6.06";"0";"CHEMBL4834290";"Inhibition of TRKB (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4831559";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 48.0 hr"
"CHEMBL3661464";"";"0";"433.90";"0";"4.47";"4";"CC(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cc3)c2)c2cncnc21";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"19.35";"0.37";"3.93";"9.35";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL3661466";"";"0";"424.46";"0";"3.69";"5";"CC(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(C#N)cc3)c2)c2cncnc21";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"17.38";"0.31";"3.69";"6.50";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL601719";"CRIZOTINIB";"4";"450.35";"1";"5.04";"63, Crizotinib, PF-02341066";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.32";"0.40";"3.66";"11.15";"0";"CHEMBL1825460";"Inhibition of TRKB";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821723";"1";"Scientific Literature";"J. Med. Chem.";"2011";"None";""
"CHEMBL4850588";"";"0";"435.84";"0";"4.86";"11b";"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3ccccc3Cl)n2)cc1";"IC50";"'='";"102.72";"nM";"6.99";"";"";"UO_0000065";"16.03";"0.32";"2.13";"8.85";"0";"CHEMBL4824345";"Inhibition of TRKB (unknown origin) measured after 40 mins by HTRF";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4823267";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr"
"CHEMBL4161036";"";"0";"532.57";"1";"4.46";"8";"Cc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12";"IC50";"'='";"9.37";"nM";"8.03";"";"";"UO_0000065";"15.07";"0.28";"3.57";"12.21";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4438527";"";"0";"631.78";"2";"6.35";"9q";"Cc1c(C#Cc2cnc3cnc(-c4ccc(N)cc4)cn23)cccc1C(=O)Nc1cc(CN2CCN(C)CC2)cc(-c2ccccc2)c1";"IC50";"'='";"24.19";"nM";"7.62";"";"";"UO_0000065";"12.06";"0.22";"1.27";"8.30";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL3889654";"LAROTRECTINIB";"4";"428.44";"0";"2.95";"2; LOXO-101";"O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1";"IC50";"'='";"5.21";"nM";"8.28";"";"";"UO_0000065";"19.33";"0.36";"5.33";"9.63";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4783042";"";"0";"416.48";"0";"4.83";"8f";"CC(C)N(C(=O)Nc1cnn2ccc(N[C@H](C)c3cc(F)ccc3F)nc12)C(C)C";"IC50";"'='";"5.5";"nM";"8.26";"";"";"UO_0000065";"19.83";"0.38";"3.43";"11.08";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4758658";"";"0";"388.38";"0";"2.39";"8e";"C[C@@H](Nc1ccn2ncc(NC(=O)N3CC(O)C3)c2n1)c1cc(F)ccc1F";"IC50";"'='";"153.0";"nM";"6.82";"";"";"UO_0000065";"17.55";"0.33";"4.43";"7.19";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4762176";"";"0";"430.46";"0";"3.42";"8c";"C[C@@H](Nc1ccn2ncc(NC(=O)N3CCCC(CO)C3)c2n1)c1cc(F)ccc1F";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"17.41";"0.33";"4.07";"7.91";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL3298266";"";"0";"494.56";"0";"4.15";"T2; Type II";"COc1cc(-c2cn(CC(=O)Nc3cc(C4CC4)nn3-c3ccccc3)nn2)ccc1-n1cnc(C)c1";"IC50";"'='";"132.2";"nM";"6.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3997038";"Inhibition of recombinant human TrkB expressed in DHFR deficient CHO cells assessed as inhibition of human brain-derived neurotrophic factor-induced calcium influx by Fluo-4 AM dye based assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3994638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4090531";"";"0";"499.56";"0";"4.09";"A1";"CCOc1nn(-c2ccccc2)c(NC(=O)N[C@@H]2CN(CCOC)C[C@H]2c2ccc(F)c(F)c2)c1C";"IC50";"'='";"1303.7";"nM";"5.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3997038";"Inhibition of recombinant human TrkB expressed in DHFR deficient CHO cells assessed as inhibition of human brain-derived neurotrophic factor-induced calcium influx by Fluo-4 AM dye based assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3994638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4793380";"";"0";"423.48";"0";"4.34";"17d";"CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1";"IC50";"'='";"68.0";"nM";"7.17";"";"";"UO_0000065";"16.93";"0.32";"2.83";"5.68";"0";"CHEMBL4767040";"Inhibition of recombinant human TRKB (455 to end residues) using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765237";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"TIME = 0.6667 hr"
"CHEMBL4782487";"";"0";"429.48";"0";"2.98";"9g";"C[C@H](c1cc(F)ccc1F)N(C)c1ccn2ncc(NC(=O)N3CCN(C)CC3)c2n1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"17.28";"0.33";"4.44";"10.75";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4570381";"";"0";"506.53";"2";"5.24";"7g";"CCN(c1cncnc1)[C@@H]1Cc2ccc(C(=O)Nc3cc(-n4cnc(C)c4)cc(C(F)(F)F)c3)cc2C1";"IC50";"'='";"569.0";"nM";"6.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4407672";"Inhibition of His-tagged human TrkB expressed in baculovirus expression system using Tyr1 peptide as substrate after 1.5 hrs by FRET-based Z-LYTE assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406813";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4748276";"";"0";"478.94";"0";"3.20";"13";"CC(C)(CO)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cc3)c2)c2cnc(N)nc21";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.16";"0.35";"5.50";"6.40";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL104519";"";"0";"397.46";"0";"2.59";"4a22";"CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2";"IC50";"'='";"4.52";"nM";"8.35";"";"";"UO_0000065";"21.00";"0.41";"5.75";"9.33";"0";"CHEMBL4765714";"Inhibition of TrkB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765228";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";""
"CHEMBL104333";"";"0";"383.43";"0";"2.33";"2a22";"COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C";"IC50";"'='";"3.92";"nM";"8.41";"";"";"UO_0000065";"21.93";"0.43";"6.08";"8.13";"0";"CHEMBL4765714";"Inhibition of TrkB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765228";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";""
"CHEMBL4204174";"";"0";"502.49";"1";"3.70";"2";"Cn1cc(-c2ccc(OC3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3)c(C(N)=O)c2)cn1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"16.67";"0.32";"4.68";"8.40";"0";"CHEMBL4195800";"Antagonist activity at prolink-tagged TrkB in human U2OS cells assessed as inhibition of BDNF-induced receptor phosphorylation by measuring reduction in EA-tagged SH2 protein recruitment preincubated for 30 mins followed by BDNF stimulation measured after 2 hrs by PathHunter enzyme complementation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190406";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL1896117";"";"0";"346.22";"0";"4.74";"2";"Cc1cc(NC(=O)c2ccc(Cl)cc2Cl)n(-c2ccccc2)n1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4309192";"Antagonist activity at prolink-tagged TrkB (unknown origin) expressed in cells assessed as inhibition of BDNF-induced receptor phosphorylation by measuring reduction in EA-tagged SH2 protein recruitment preincubated for 30 mins followed by BDNF addition measured after 2 hrs by PathHunter enzyme complementation assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4308832";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4556229";"";"0";"524.62";"1";"4.94";"V1";"Nc1c(N2CCN(C3CCCCC3)CC2)cc(Nc2ccc(C(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O";"IC50";"'='";"94000.0";"nM";"4.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343624";"Inhibition of wild type human N-terminal GST-fusion tagged TRKB kinase domain (456 to 822 residues) expressed in baculovirus expression system by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342423";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";""
"CHEMBL4468886";"";"0";"392.46";"1";"5.34";"6";"Cc1ncc(NC(=O)NC2c3ccccc3-c3ccccc32)c(-c2ccccc2)n1";"IC50";"'>'";"8100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4840570";"Inhibition of BDNF-activated full length TRKB (unknown origin) by Cell-based beta-galactosidase PathHunter assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840303";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";""
"CHEMBL4531144";"";"0";"552.99";"1";"4.80";"9e";"CN1CCN(Cc2cc(NC(=O)c3cccc(C#Cc4cnc5cnccn45)c3Cl)cc(C(F)(F)F)c2)CC1";"IC50";"'='";"253.65";"nM";"6.60";"";"";"UO_0000065";"11.93";"0.23";"1.80";"10.03";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4569549";"";"0";"611.79";"2";"5.98";"9p";"Cc1c(C#Cc2cnc3cnc(-c4ccc(N)cc4)cn23)cccc1C(=O)Nc1cc(CN2CCN(C)CC2)cc(C(C)(C)C)c1";"IC50";"'='";"15.59";"nM";"7.81";"";"";"UO_0000065";"12.76";"0.23";"1.83";"8.51";"0";"CHEMBL4354363";"Inhibition of recombinant human His-tagged TrkB catalytic domain (526 to 838 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4351015";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4518353";"";"0";"458.96";"0";"4.44";"G755-0328";"Cc1cccn2c(=O)cc(CSc3nnc(NC(=O)Nc4cccc(Cl)c4)s3)nc12";"IC50";"'='";"1340.8";"nM";"5.87";"";"";"UO_0000065";"12.80";"0.27";"1.43";"5.80";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4461421";"";"0";"476.95";"0";"4.58";"G755-0726";"Cc1ccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cc(Cl)ccc4n3)s2)cc1F";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.85";"0.21";"0.12";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4552667";"";"0";"438.54";"0";"4.10";"G755-0237";"Cc1ccc(C)c(NC(=O)Nc2nnc(SCc3cc(=O)n4ccccc4n3)s2)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.72";"0.21";"0.60";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4579460";"";"0";"426.52";"1";"5.69";"L365-0742";"CCn1c(CCc2ccc(NC(=O)Nc3cccc(C(C)=O)c3)cc2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.02";"0.20";"-0.99";"6.18";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL3673442";"";"0";"524.63";"1";"4.86";"BDBM164891";"COc1ccc(COc2ccc(Cn3cnc4cc(-c5cnn(C6CCNCC6)c5)ccc43)cc2OC)cn1";"IC50";"'='";"5.0";"nM";"8.30";"";"308450";"UO_0000065";"15.82";"0.29";"3.44";"9.41";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673444";"";"0";"526.60";"1";"4.59";"BDBM164893";"COc1ccc(COc2ccc(Cn3cnc4cc(-c5nnc(C6CCCNC6)o5)ccc43)cc2OC)cn1";"IC50";"'='";"439.0";"nM";"6.36";"";"308452";"UO_0000065";"12.07";"0.22";"1.77";"5.81";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673447";"";"0";"515.66";"2";"5.03";"BDBM164896";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CCC(C(C)(C)N)CC5)ccc43)cc2OC)cn1";"IC50";"'='";"574.0";"nM";"6.24";"";"308455";"UO_0000065";"12.10";"0.22";"1.21";"7.12";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678288";"";"0";"497.60";"0";"4.98";"BDBM164946";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(C#CC5CCCCC5)cnc43)cc2OC)cn1";"IC50";"'='";"80.0";"nM";"7.10";"";"308505";"UO_0000065";"14.26";"0.26";"2.12";"7.29";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4573099";"";"0";"477.59";"0";"4.28";"Z19503255";"CCOc1ccccc1-n1nnnc1SCC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.84";"0.19";"0.42";"4.71";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL104333";"";"0";"383.43";"0";"2.33";"2a22";"COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C";"IC50";"'='";"110.95";"nM";"6.96";"";"";"UO_0000065";"18.14";"0.35";"4.62";"6.72";"0";"CHEMBL4765712";"Inhibition of GAL4 fused TrkB (unknown origin) expressed in MG87 cells transfected with pFA2-Elk plasmid and pFR-luciferase plasmid measured for 18 hrs by luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MG87";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765228";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"TIME = 18.0 hr"
"CHEMBL4778721";"";"0";"349.34";"1";"5.20";"7d";"Fc1cc(F)cc(Oc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"24.04";"0.44";"3.20";"16.53";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4791453";"";"0";"444.49";"0";"3.44";"9c";"C[C@H](c1cc(F)ccc1F)N(C)c1ccn2ncc(NC(=O)N3CCCC(CO)C3)c2n1";"IC50";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"16.89";"0.32";"4.07";"8.73";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4777109";"";"0";"432.50";"0";"2.97";"14b";"C[C@H](c1cc(F)ccc1F)N(C)c1ccn2ncc(NC(=S)N3CC[C@H](O)C3)c2n1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"17.46";"0.34";"4.58";"10.96";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4784645";"";"0";"402.41";"0";"2.78";"8a";"C[C@@H](Nc1ccn2ncc(NC(=O)N3CC[C@H](O)C3)c2n1)c1cc(F)ccc1F";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"21.14";"0.40";"5.73";"8.98";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4858347";"";"0";"480.56";"0";"3.94";"19t";"CN1CCN(c2cccc(C(=O)Nc3n[nH]c4c3CN(Cc3cc(F)cc(F)c3)C4(C)C)c2)CC1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"13.99";"0.26";"2.78";"9.96";"0";"CHEMBL4840465";"Inhibition of N-terminal GST-tagged human TRKB (456 to 822 residues) expressed in baculovirus infected Sf21 cells using TK as substrate in presence of ATP measured after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840303";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr"
"CHEMBL3955023";"";"0";"456.43";"0";"4.10";"7";"CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3ccc(C(F)(F)F)n3)c2)c2cnccc21";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"17.87";"0.34";"4.05";"8.61";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL4212531";"PF-06273340";"1";"479.93";"0";"2.60";"14; PF-06273340";"CC(C)(CO)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cn3)c2)c2cnc(N)nc21";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"17.50";"0.34";"5.80";"5.64";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL4799455";"";"0";"333.34";"1";"5.07";"7b";"Fc1cc(F)cc(-c2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"728.8";"nM";"6.14";"";"";"UO_0000065";"18.41";"0.34";"1.07";"14.76";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4795019";"";"0";"344.39";"0";"4.88";"7s";"Fc1cccc(CNc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"24.13";"0.44";"3.43";"15.50";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL104519";"";"0";"397.46";"0";"2.59";"4a22";"CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2";"IC50";"'='";"41.07";"nM";"7.39";"";"";"UO_0000065";"18.58";"0.36";"4.80";"8.26";"0";"CHEMBL4765712";"Inhibition of GAL4 fused TrkB (unknown origin) expressed in MG87 cells transfected with pFA2-Elk plasmid and pFR-luciferase plasmid measured for 18 hrs by luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MG87";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765228";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"TIME = 18.0 hr"
"CHEMBL3673473";"";"0";"499.57";"0";"3.65";"BDBM164924";"COc1ccc(COc2ccc(Cn3cnc4cc(C5=CC6(O)CCCN5C6)cnc43)cc2OC)cn1";"IC50";"'='";"150.0";"nM";"6.82";"";"308483";"UO_0000065";"13.66";"0.25";"3.17";"7.20";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678305";"";"0";"497.56";"1";"5.10";"BDBM164968";"COc1ccc(-c2cnc3c(c2)ncn3Cc2ccc(OC(C)c3ccc(OC)nc3)c(OC)c2)cn1";"IC50";"'='";"61.0";"nM";"7.21";"";"308522";"UO_0000065";"14.50";"0.27";"2.11";"7.72";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4849505";"";"0";"480.56";"0";"3.94";"19m";"CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(Cc3cc(F)cc(F)c3)C4(C)C)cc2)CC1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"15.72";"0.29";"3.61";"11.19";"0";"CHEMBL4840465";"Inhibition of N-terminal GST-tagged human TRKB (456 to 822 residues) expressed in baculovirus infected Sf21 cells using TK as substrate in presence of ATP measured after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840303";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr"
"CHEMBL104279";"";"0";"353.40";"0";"2.32";"2a21";"Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21";"IC50";"'='";"7.62";"nM";"8.12";"";"";"UO_0000065";"22.97";"0.44";"5.80";"8.62";"0";"CHEMBL4765714";"Inhibition of TrkB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765228";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";""
"CHEMBL4438748";"";"0";"457.49";"0";"4.13";"12j";"CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4379470";"Inhibition of recombinant human TRKB (455 to end residues) using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376834";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3661485";"";"0";"429.48";"0";"3.35";"8";"CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3ccc(C4CC4)n3)c2)c2cncnc21";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"19.55";"0.36";"5.05";"7.81";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL3666257";"";"0";"444.50";"0";"2.93";"11";"CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3ccc(C4CC4)n3)c2)c2cnc(N)nc21";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"18.67";"0.34";"5.37";"6.21";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL4468886";"";"0";"392.46";"1";"5.34";"39";"Cc1ncc(NC(=O)NC2c3ccccc3-c3ccccc32)c(-c2ccccc2)n1";"IC50";"'>'";"81000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4330192";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330054";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL575448";"BMS-754807";"2";"461.51";"0";"3.61";"13";"C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"18.20";"0.34";"4.79";"7.23";"0";"CHEMBL4330192";"Inhibition of TRKB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330054";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4779607";"";"0";"376.41";"1";"5.04";"7o";"CN(Cc1cc(F)cc(F)c1)c1ccc2[nH]nc(/C=C/c3ccccn3)c2c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"21.51";"0.39";"3.06";"18.07";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4755698";"";"0";"405.46";"0";"2.83";"B16";"C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4720263";"Inhibition of recombinant human TRKb using Ulight-Poly GAT[EAY(1:1:1)]n as substrate incubate for 10 mins by LANCE assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"TIME = 0.1667 hr"
"CHEMBL4788418";"";"0";"468.46";"0";"2.12";"13b";"C[C@H](c1cc(F)ccc1F)N(C)c1ccn2ncc(Nc3c(N4CC[C@H](O)C4)c(=O)c3=O)c2n1";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"15.07";"0.28";"4.94";"6.85";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4745371";"";"0";"402.41";"0";"2.41";"9e";"C[C@H](c1cc(F)ccc1F)N(C)c1ccn2ncc(NC(=O)N3CC(O)C3)c2n1";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"18.00";"0.34";"4.83";"8.42";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4778629";"";"0";"418.47";"0";"2.94";"14a";"C[C@@H](Nc1ccn2ncc(NC(=S)N3CC[C@H](O)C3)c2n1)c1cc(F)ccc1F";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"16.87";"0.33";"4.12";"9.08";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4749323";"";"0";"415.45";"0";"2.96";"8g";"C[C@@H](Nc1ccn2ncc(NC(=O)N3CCN(C)CC3)c2n1)c1cc(F)ccc1F";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"15.98";"0.30";"3.68";"8.53";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4754926";"";"0";"404.42";"0";"3.07";"8d";"CCC(CO)NC(=O)Nc1cnn2ccc(N[C@H](C)c3cc(F)ccc3F)nc12";"IC50";"'='";"102.0";"nM";"6.99";"";"";"UO_0000065";"17.29";"0.33";"3.92";"6.75";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4874046";"";"0";"417.39";"0";"4.35";"12f";"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(Nc3ccccc3OC)n2)cc1";"IC50";"'='";"39.44";"nM";"7.40";"";"";"UO_0000065";"17.74";"0.34";"3.05";"8.40";"0";"CHEMBL4824345";"Inhibition of TRKB (unknown origin) measured after 40 mins by HTRF";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4823267";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr"
"CHEMBL4779366";"";"0";"357.36";"0";"4.81";"7h";"Fc1cc(F)cc(C#Cc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4795806";"";"0";"326.40";"0";"4.74";"7q";"C(=C/c1n[nH]c2ccc(NCc3ccccc3)cc12)\c1ccccn1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"27.45";"0.49";"4.22";"16.71";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4780049";"";"0";"378.84";"1";"5.53";"7u";"Fc1cc(Cl)cc(CNc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"15.4";"nM";"7.81";"";"";"UO_0000065";"20.62";"0.40";"2.28";"14.58";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL388978";"STAUROSPORINE";"0";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"0.093";"nM";"10.03";"";"";"UO_0000065";"21.50";"0.39";"5.68";"14.44";"0";"CHEMBL4720522";"Inhibition of human TRKB using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715818";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3678303";"";"0";"470.53";"0";"4.43";"BDBM164966";"COc1ccc(C(C)Oc2ccc(Cn3cnc4cc(-c5cnn(C)c5)cnc43)cc2OC)cn1";"IC50";"'='";"13.0";"nM";"7.89";"";"308520";"UO_0000065";"16.76";"0.31";"3.46";"8.85";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4553953";"";"0";"492.51";"0";"4.81";"G755-0359";"Cc1cccn2c(=O)cc(CSc3nnc(NC(=O)Nc4cccc(C(F)(F)F)c4)s3)nc12";"IC50";"'='";"63.7";"nM";"7.20";"";"";"UO_0000065";"14.61";"0.30";"2.39";"7.10";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4467204";"";"0";"418.93";"1";"5.96";"L365-1395";"Cc1ccc(NC(=O)Nc2ccc(CCc3nc4ccccc4n3C)cc2)cc1Cl";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.22";"0.21";"-1.26";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4783102";"";"0";"344.39";"0";"4.88";"7r";"Fc1ccccc1CNc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1";"IC50";"'='";"36.2";"nM";"7.44";"";"";"UO_0000065";"21.61";"0.39";"2.56";"13.88";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL169390";"";"0";"294.36";"0";"3.50";"3";"Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCCC1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"19.89";"0.36";"2.35";"7.61";"0";"CHEMBL4834290";"Inhibition of TRKB (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4831559";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 48.0 hr"
"CHEMBL4787950";"";"0";"347.37";"0";"5.00";"7a";"Fc1cc(F)cc(Cc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"25.58";"0.47";"3.89";"21.38";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4800162";"";"0";"361.40";"1";"5.19";"7g";"Fc1cc(F)cc(CCc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"8.5";"nM";"8.07";"";"";"UO_0000065";"22.33";"0.41";"2.88";"19.41";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4792043";"";"0";"376.37";"0";"4.66";"7j";"O=C(Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1";"IC50";"'='";"243.7";"nM";"6.61";"";"";"UO_0000065";"17.57";"0.32";"1.95";"9.36";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4777099";"";"0";"363.37";"0";"4.99";"7l";"Fc1cc(F)cc(OCc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"22.41";"0.41";"3.15";"16.03";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4787602";"";"0";"423.29";"1";"5.64";"7v";"Fc1cc(Br)cc(CNc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"30.6";"nM";"7.51";"";"";"UO_0000065";"17.75";"0.38";"1.87";"14.02";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4800232";"";"0";"374.42";"0";"4.89";"7x";"COc1cc(F)cc(CNc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1";"IC50";"'='";"26.7";"nM";"7.57";"";"";"UO_0000065";"20.23";"0.37";"2.68";"12.05";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL3889654";"LAROTRECTINIB";"4";"428.44";"0";"2.95";"1";"O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"20.16";"0.38";"5.69";"10.04";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4854822";"";"0";"424.48";"0";"2.39";"4";"CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(O)ccc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"8500.0";"nM";"5.07";"";"";"UO_0000065";"11.95";"0.22";"2.68";"5.04";"0";"CHEMBL4834290";"Inhibition of TRKB (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4831559";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 48.0 hr"
"CHEMBL4744936";"";"0";"451.44";"0";"4.14";"1";"CC(C)n1cc(C(=O)c2ccnc(NC(=O)Nc3ccc(F)cc3F)c2)c2c(N)ncnc21";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"18.39";"0.34";"4.16";"6.49";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL4790022";"";"0";"448.91";"0";"4.06";"3";"CC(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cc3)c2)c2c(N)ncnc21";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.38";"0.37";"4.64";"7.51";"0";"CHEMBL4681385";"Inhibition of human TrkB expressed in human U2OS cells pre-incubated 30 mins before neurotrophin addition and measured after 2 hrs by luminescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Bone";"U2OS";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680090";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 2.5 hr"
"CHEMBL4574596";"";"0";"421.49";"0";"2.90";"Z65952805";"Cc1ccc(-n2nc(C)cc2NC(=O)CSc2nnnn2-c2ccc(O)cc2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.15";"0.21";"1.80";"4.24";"0";"CHEMBL4399999";"Inhibition of recombinant full length human TrkB transfected in CHO cells assessed as inhibition of NGF-stimulated calcium influx by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4756923";"";"0";"454.44";"0";"2.09";"13a";"C[C@@H](Nc1ccn2ncc(Nc3c(N4CC[C@H](O)C4)c(=O)c3=O)c2n1)c1cc(F)ccc1F";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"13.88";"0.26";"4.22";"5.64";"0";"CHEMBL4678167";"Inhibition of Trk-B (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673327";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4798527";"";"0";"548.57";"2";"5.17";"13an";"Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12";"IC50";"'='";"899.0";"nM";"6.05";"";"";"UO_0000065";"11.02";"0.21";"0.88";"5.08";"0";"CHEMBL4766192";"Inhibition of human recombinant TRKB (455 to end residues) using poly(Glu,Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765233";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.6667 hr"
"CHEMBL322153";"";"0";"411.48";"0";"2.93";"2a25";"COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C";"IC50";"'='";"15.25";"nM";"7.82";"";"";"UO_0000065";"19.00";"0.37";"4.89";"9.69";"0";"CHEMBL4765714";"Inhibition of TrkB (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765228";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";""
"CHEMBL4475494";"";"0";"482.52";"0";"1.88";"None";"CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O";"IC50";"";"259.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4886110";"TrkB Kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4879554";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";""
"CHEMBL4283353";"";"0";"504.72";"2";"5.31";"3";"CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1";"IC50";"'='";"24.5";"nM";"7.61";"";"";"UO_0000065";"15.08";"0.28";"2.30";"10.96";"0";"CHEMBL4838727";"Inhibition of N-terminal GST-tagged TRKB (456 to 822 residues) (unknown origin) cytoplasmic domain expressed in Sf21 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4837224";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";""
"CHEMBL4866306";"";"0";"467.52";"0";"4.03";"19h";"CC1(C)c2[nH]nc(NC(=O)c3ccc(N4CCOCC4)cc3)c2CN1Cc1cccc(F)c1F";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"15.95";"0.30";"3.43";"10.15";"0";"CHEMBL4840465";"Inhibition of N-terminal GST-tagged human TRKB (456 to 822 residues) expressed in baculovirus infected Sf21 cells using TK as substrate in presence of ATP measured after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840303";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr"
"CHEMBL4856835";"";"0";"480.56";"0";"3.94";"19l";"CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(Cc3cccc(F)c3F)C4(C)C)cc2)CC1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"15.89";"0.30";"3.70";"11.32";"0";"CHEMBL4840465";"Inhibition of N-terminal GST-tagged human TRKB (456 to 822 residues) expressed in baculovirus infected Sf21 cells using TK as substrate in presence of ATP measured after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840303";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr"
"CHEMBL4862580";"";"0";"467.52";"0";"4.03";"19p";"CC1(C)c2[nH]nc(NC(=O)c3cccc(N4CCOCC4)c3)c2CN1Cc1cc(F)cc(F)c1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"14.48";"0.27";"2.74";"9.21";"0";"CHEMBL4840465";"Inhibition of N-terminal GST-tagged human TRKB (456 to 822 residues) expressed in baculovirus infected Sf21 cells using TK as substrate in presence of ATP measured after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840303";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr"
"CHEMBL3673468";"";"0";"526.60";"2";"3.52";"BDBM164917";"COc1ccc(COc2ccc(Cn3cnc4cc(-n5cc(C6CCCNC6)nn5)cnc43)cc2OC)cn1";"IC50";"'='";"18.0";"nM";"7.75";"";"308476";"UO_0000065";"14.71";"0.27";"4.22";"6.79";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678292";"";"0";"484.56";"0";"4.62";"BDBM164950";"COc1ccc(COc2ccc(C(C)n3c(N)nc4cc(-c5cnn(C)c5)ccc43)cc2OC)cn1";"IC50";"'='";"1.0";"nM";"9.00";"";"308509";"UO_0000065";"18.57";"0.34";"4.38";"8.80";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4862017";"";"0";"467.52";"0";"4.03";"19i";"CC1(C)c2[nH]nc(NC(=O)c3ccc(N4CCOCC4)cc3)c2CN1Cc1cc(F)cc(F)c1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"16.19";"0.30";"3.54";"10.30";"0";"CHEMBL4840465";"Inhibition of N-terminal GST-tagged human TRKB (456 to 822 residues) expressed in baculovirus infected Sf21 cells using TK as substrate in presence of ATP measured after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840303";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr"
"CHEMBL4532509";"";"0";"472.98";"0";"4.75";"G755-0540";"Cc1ccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cc(C)ccc4n3)s2)c(Cl)c1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.57";"0.22";"0.25";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4457208";"";"0";"446.55";"1";"6.76";"L365-3504";"Cc1ccc(NC(=O)Nc2ccc(CCc3nc4ccccc4n3-c3ccccc3)cc2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.52";"0.19";"-2.06";"7.97";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4466913";"";"0";"438.54";"0";"4.10";"G755-0551";"Cc1cccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cc(C)ccc4n3)s2)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"10.72";"0.21";"0.60";"4.64";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4553513";"";"0";"402.52";"1";"5.71";"L365-0072";"CSc1cccc(NC(=O)Nc2ccc(CCc3nc4ccccc4[nH]3)cc2)c1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.67";"0.22";"-1.01";"6.73";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4446168";"";"0";"470.61";"0";"4.51";"G755-0564";"CSc1cccc(NC(=O)Nc2nnc(SCc3cc(=O)n4cc(C)ccc4n3)s2)c1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.62";"0.22";"0.49";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4548111";"";"0";"482.55";"0";"3.58";"G755-0437";"COC(=O)c1ccccc1NC(=O)Nc1nnc(SCc2cc(=O)n3ccc(C)cc3n2)s1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.36";"0.21";"1.42";"3.92";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL4572771";"";"0";"460.49";"0";"4.07";"G755-0362";"Cc1cccn2c(=O)cc(CSc3nnc(NC(=O)Nc4ccc(F)cc4F)s3)nc12";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.86";"0.22";"0.93";"4.94";"0";"CHEMBL4308450";"Inhibition of human full length TRKB expressed in CHO cells assessed as decrease in NGF-induced Ca2+ flux by Calcium 4 dye-based FLIPR TETRA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304826";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";""
"CHEMBL388978";"STAUROSPORINE";"0";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"0.0636";"nM";"10.20";"";"";"UO_0000065";"21.86";"0.40";"5.85";"14.68";"0";"CHEMBL4328638";"Inhibition of human TRKB using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325871";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL3137331";"DEFACTINIB";"2";"510.50";"1";"2.40";"EUB0000138";"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1";"IC50";"'='";"54.87";"nM";"7.26";"";"";"UO_0000065";"14.22";"0.28";"4.86";"5.11";"0";"CHEMBL4824345";"Inhibition of TRKB (unknown origin) measured after 40 mins by HTRF";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4823267";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr"
"CHEMBL3673450";"";"0";"473.58";"0";"3.83";"BDBM164899";"COc1ccc(COc2ccc(Cn3cnc4cc(N5CCN(C)CC5)ccc43)cc2OC)cn1";"IC50";"'='";"443.0";"nM";"6.35";"";"308458";"UO_0000065";"13.42";"0.25";"2.52";"9.79";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673471";"";"0";"497.60";"0";"4.93";"BDBM164922";"COc1ccc(COc2ccc(Cn3cnc4cc(C5=CC6(C)CCCN5C6)cnc43)cc2OC)cn1";"IC50";"'='";"118.0";"nM";"6.93";"";"308481";"UO_0000065";"13.92";"0.26";"2.00";"9.30";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3673486";"";"0";"468.52";"0";"4.12";"BDBM164937";"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5ccncc5)cnc43)cc2OC)cn1";"IC50";"'='";"0.7";"nM";"9.15";"";"308496";"UO_0000065";"19.54";"0.36";"5.03";"8.31";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678283";"";"0";"524.50";"1";"4.95";"BDBM164941";"COc1cc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"308500";"UO_0000065";"18.49";"0.35";"4.75";"9.49";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3678291";"";"0";"511.59";"1";"4.33";"BDBM164949";"COc1cc2c(cn1)C(Oc1ccc(Cn3c(N)nc4cc(-c5cnn(C)c5)cnc43)cc1OC)CCC2";"IC50";"'='";"41.0";"nM";"7.39";"";"308508";"UO_0000065";"14.44";"0.27";"3.06";"6.42";"0";"CHEMBL3705888";"Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkB (0.6 nM, Carna 08-187) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 μM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 300 pM TrkB, 1.5 μM peptide substrate and 70 μM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij, 0.1% CR-3, 0.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638818";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4877347";"";"0";"518.71";"2";"5.54";"24";"CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"13.81";"0.26";"1.62";"7.45";"0";"CHEMBL4838727";"Inhibition of N-terminal GST-tagged TRKB (456 to 822 residues) (unknown origin) cytoplasmic domain expressed in Sf21 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4837224";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";""
"CHEMBL4778234";"";"0";"344.39";"0";"4.88";"7t";"Fc1ccc(CNc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)cc1";"IC50";"'='";"78.9";"nM";"7.10";"";"";"UO_0000065";"20.62";"0.37";"2.22";"13.25";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
"CHEMBL4780099";"";"0";"376.41";"1";"5.58";"7ma";"C[C@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1";"IC50";"'='";"22.2";"nM";"7.65";"";"";"UO_0000065";"20.33";"0.37";"2.07";"14.28";"0";"CHEMBL4772613";"Inhibition of TrkB (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4898";"Neurotrophic tyrosine kinase receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765391";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 2.0 hr"
